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CHAPTER I 
 
THE OMICS ERA: A PARALLEL EVOLUTION OF SYSTEMS BIOLOGY WITH 
BIOANALYTICAL METHODOLOGY 
 
 
 
 In literal meaning, systems biology is defined as the comprehensive, quantitative 
analysis of the manner in which all of the components of a biological system interact over 
time.1  Systems biology is hypothesis-driven, global, quantitative, iterative, integrative 
and dynamic.2  The systems approach begins with acquisition of large global sets of 
biological data from as much information and as many biological processes possible.2  
From a cell biology perspective, systems biology is a major contributor to the 
development and integration of traditional and emerging bioanalytical techniques for 
measuring small perturbations of the inner workings of a cell.   
 Cells are living systems full of various functional molecules which eventually 
determine the phenotype of the cells.  Such molecules include mRNA transcribed from 
DNA, proteins translated from mRNA, and various metabolites of small molecular mass 
generated by various enzymatic activities. (figure 1)  While one might think that every 
biological process is dictated by DNA sequence, the vast majority of genetic information 
leads to minimal insight into the functionality of biomolecules and the regulatory 
mechanisms involved in generating such molecules.3  To explore all aspects of cellular 
processes,  the last decade has witnessed significant growth in bioanalytical technologies  
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pertaining to molecular biology assays in order to measure various cellular molecules 
including mRNA, proteins and metabolites.  This evolution has led to the generation of 
several new 'omic' research fields including transcriptomics, proteomics, metabolomics, 
and so on.4  These 'omic' experimental approaches exhibit three key characteristics 
beginning with a non-traditional shotgun, top-down experimental methodology.4  
Secondly, 'omic' research attempts to understand the 'whole-picture' or the grand 
'integrated system' by incorporating cross-correlated interactions between a vast array of 
molecular species.5  Finally, all emerging 'omic' research features a high-throughput 
approach that generates large waves of data that require significant statistical and 
computational processing.  Collectively, the 'omic' field of research is driving the 
development of many sensitive and high-throughput bioanalytical techniques that rely on 
	  
 
Figure 1.  Schematic of the Fundamental Principles of Biological Processes. 
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the emerging field of 'bioinformatics' to classify, evaluate and transfer interrelations into 
systems biological models for conceptual analysis.6   
 While many believe the term 'omic' to be of Greek origin, there are no such 
correlations.  Genomics  was the foundation of "omic" research notation and was derived 
from a combination of the words 'gene' and 'chromosome' which indicated the complete 
set of chromosomes, and the genes contained in them.  The 'omics' field has emerged as 
meaning an approach capable of generating a comprehensive data set.   
 In 1980, the Department of Energy (DOE) and the National Institute of Health 
(NIH) initiated the Human Genome Project (HGP) with an ultimate goal of accurately 
sequencing the human genome.7  By 2003, the complete human genome was elucidated 
and accessible by all.7  Without the rapid advances in capillary electrophoresis (CE) and 
capillary array electrophoresis (CAE), the HGP would not have been achieved two years 
ahead of schedule. Although CE research began in the early 1960s, investment in the 
technique did not become popular until advanced methods of DNA sequencing, namely 
CAE,  began to emerge in the mid 1990s.8,9  Still today, CAE continues to be the gold 
standard for genomic research and one will find benchtop CAE DNA sequencers in most 
molecular biology research departments.  Currently, bioanalytical techniques in genomics 
are developing more from an engineering standpoint that aims to increase throughput and 
reduce overall time and cost of analysis.  Eventually, genetic screening will be an integral 
part of an individual's medical assessment. 
 With the discovery of the human genome, also came an influx in proteomic 
research and development.  The first reported proteomic analysis utilized nanometal 
particle assisted laser desorption mass spectrometry to obtain large biomolecular spectra 
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that could be correlated to protein molecular weight.10  Shortly after, emergence of 
matrix-assisted laser desorption/ionization (MALDI) time-of-flight (TOF) mass 
spectrometry (MS)11 and electrospray ionization (ESI) mass spectrometry12 began to be 
the cornerstones for proteomic analysis.  Implementation of proteolytic enzymes such as 
tyrpsin and chymotrypsin allowed for discrete peptide identification and the introduction 
of collision-induced dissociation (CID) provided the necessary means of secondary 
fragmentation (MS2) for amino acid assignment.13  Current proteomic techniques have 
evolved at a similar if not faster rate than genomic instrumentation but the cost of 
proteomic instrumentation (primarily MS technology) as a whole has not followed such a 
trend.  New approaches to multi-dimensional online chromatography and nanoscale 
capillary chromatography have drastically reduced sample preparation as well as 
increased sample throughput.  A current need is the development and validation of 
methods to decipher post-translational modifications with high accuracy.  Additionally, 
the emergence of bioinformatics as a data interpretation tool shows promise for future 
bioanalytical approaches in proteomic research.13 
 The next emerging research area is that of transcriptomics.  Transcriptomics 
builds on the knowledge of genomes.  Although the genome is basically the same in 
every cell of an organism, different cells show different patterns of gene expression to 
serve various physiological functions but also to respond to external stimuli, such as 
chemical stressors.14  The term 'gene expression' refers to the synthesis, or transcription, 
of RNA from a gene; thus, the transcriptome constitutes a snapshot of all actively 
expressed genes at any given time.  An overwhelming amount of transcriptomic research 
revolves around new advances in DNA microarray technology that utilizes 
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complementary DNA (cDNA) detection strategies.15  Microarray analysis continues to 
evolve at a rapid rate due to the popularity of commercial platforms  and the wealth of 
data that is acquired.  Next generation RNA sequencers are currently being developed 
and will eventually overcome most of the current limitations.  RNA sequencers will 
eventually overcome most of the current limitations and allow for whole transcriptome 
shotgun sequencing that will enable the assembly of full cellular transcripts for a single 
sample.16  Furthermore, digital acquisition of sequence reads will ultimately provide a 
reliable quantitative assessment over a wide range of expression levels with detection 
limits down to a few transcripts per cell without the need for any previous knowledge of 
the transcript of interest.17 
 Until recently, 'omic' areas of research were narrowly defined by large 
biomolecules of  > 1500 Daltons that are associated directly or indirectly involved in 
gene expression but in 1999, the term, metabolomics was coined.18  Metabolomics is 
defined as the quantitative measure of the dynamic multiparametric metabolic response 
of living systems to pathophysiologic stimuli or genetic modification and is concerned 
with the high throughput identification and quantitation of the small molecule metabolites 
of the metabolome.19  The metabolome constitutes the interaction between small 
molecules, such as metabolic substrates and products, lipids, small peptides, vitamins and 
other protein cofactors.20   The profiling of metabolites was first reported in the early 
1950s with little progress for the next half century.21   
 Many recent developments in metabolomics have occurred due to major advances 
in analytical techniques (LC-MS, LC-NMR) and bioinformatics tools (Chemometrics).20  
Nuclear magnetic resonance spectroscopy (NMR)-based metabolomics offer key 
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advantages over MS techniques due to nondestructive, cost-effective and quick sample 
preparation and analysis.  For the majority of cellular metabolites, LC-MS or GC-MS are 
the primary means of quantitative analysis with each offering high selectivity and 
sensitivity.22  Metabolomic research and technology is grossly immature  in comparison 
to genomics or proteomics but this is to be expected due to the drastic chemical diversity 
of cellular metabolites.  Each 'omic' technology evolves to identify and quantitate a 
specific analyte such as individual nucleotides, tryptic digest peptides or RNA/cDNA 
fragments.  Metabolomics on the other hand requires a vast array of analytical techniques 
that range from enzyme-immobilized electrochemical detection to simple UV/vis 
spectroscopy.23  The likelihood of condensing such a large number of analytical methods 
into a single high-throughput technique is very unlikely with the only possible exception 
attributed to exponential development of microfluidic devices. This highlights the major 
hurdle for metabolomics which is the absence of a singular technique for high-throughput 
global analysis of the total cellular  metabolic state.  
 The emergence of 'omic' focused research has dramatically changed the field of 
chemical biology to exist as a vastly networked collaboration of disciplines including 
biochemistry, cellular biology, biophysics, bioengineering, biostatistics and 
bioinformatics.  Each of these disciplines exists under the confines of systems biology as 
we know it today.  The direction of future innovation lies somewhere between platform 
miniaturization for single cell measurements and a convergence of interdisciplinary 
analytical methods and materials.  Genomics and transcriptomics will likely become 
microchip-based sequencing techniques that become incorporated in limitless aspects of 
our lives.  Analytical methods in proteomic research will be greatly enhanced by new 
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innovative separation techniques both online and offline coupled with high resolution 
mass spectrometry (HR-MS).  The current field of metabolomics has already begun to 
dismantle into their respective focus of research, such as lipidomics or interactomics.24  
Of all the 'omic' fields of study, metabolomics leaves much to be desired in all aspects 
including metabolic flux, metabolite kinetics and phenotypic metabolic signatures, to 
name a few.  The analytical tools needed to elucidate the metabolome can only be 
developed with continued collaboration across all areas of life science.   
 As analytical approaches to chemical biology continue to evolve,   systems 
biology continues to amass key pieces to the overall puzzle of cellular complexity.  The 
following chapters represent pieces to that puzzle.  In chapter two, multi-dimensional 
LC-MS was performed to identify non-enzymatic fatty acid oxidation products associated 
with schistosomal hemozoin.  In chapter three, multianalyte microphysiometry was 
employed to electrochemically measure macrophage energy metabolism changes in 
response to HNE exposure and PMA activation in real-time.  To conclude, chapter four  
details the design, characterization and validation of a novel DNA-coated gold 
nanoparticle probe for identification and phenotypic classification of metastatic 
melanoma.  While different in their own right, each study builds on the use and 
development of bioanalytical techniques and reporting biomaterials. 
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CHAPTER II 
 
IDENTIFICATION OF HYDROXYEICOSATETRAENOIC ACID COMPONENTS OF 
SCHISTOSOMAL HEMOZOIN1 
 
 
Introduction 
 Schistosomiasis is a parasitic disease that chronically infects over 200 million 
people in 74 countries and is responsible for more than 200,000 deaths each year.3-5  
Based on recent reports, schistosomiasis ranks second only to malaria as a cause for 
chronic morbidity among tropical diseases.6  Parasitic infection by Schistosoma mansoni 
occurs via a complex digenetic life cycle consisting of skin penetration by free-swimming 
	  
 
Figure 2.  Worldwide Distribution of Schistosomiasis 
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cercariae that are released from infected aquatic snails of the genus Biomphalaria, 
followed by migration, maturation, and sexual reproduction in the host’s vascular system.  
Schistosome eggs typically deposit in the intestinal tissue and are excreted in the feces.  
The life cycle is completed once excreted eggs reach freshwater and hatch into free-
swimming miracidia, which, in turn, reinfect the intermediate snail hosts.  
 S. mansoni is the primary species responsible for vertebrate schistosomiasis and 
like other blood feeding organisms such as Plasmodium falciparum (malaria)7 and 
Haemoproteus columbae (avian malaria)8, the blood fluke catabolizes host hemoglobin 
(Hb) in order to obtain requisite amino acids for growth and development.  While 
residing in the hepatic portal system, adult schistosomal worms ingest large quantities of 
host red blood cells (RBCs).  In fact, it is estimated that mature female schistosomes 
consume up to 330,000 RBCs per hour.9  Erythrocytic Hb is broken down by proteolytic 
enzymes in the gut and the current paradigm suggests that heme is an end-product of Hb 
digestion.8  Although heme is an essential molecule for most living organisms, high 
concentrations of free heme are thought to elicit deleterious pro-oxidant effects such as 
free radical formation, hemolysis,10 and lipid peroxidation.11  In order to evade the 
cytotoxic effects of free heme, blood feeding organisms have developed novel 
mechanisms of heme detoxification.  In the protozoan P. falciparum, toxic free heme 
accumulates in the digestive food vacuole and is sequestered by aggregation into an inert 
crystalline pigment called hemozoin (Hz).7  S. mansoni employs a similar heme 
detoxification pathway.  During hemoglobin breakdown in the digestive cavity of the 
trematode, free heme aggregates and the subsequent pigment is regurgitated by the 
parasite into the surrounding host vasculature.  The dark-brown pigment produced during 
12	  
	  
S. mansoni infection has long been speculated to consist of a dimeric heme core and in a 
recent study by Oliveira and coworkers, X-ray powder diffraction studies unequivocally 
revealed that schistosomal pigment is structurally identical to P. falciparum hemozoin 
and its synthetic analogue, β-hematin (BH).12,13  
  
 The chemical structure of hemozoin (figure 3) consists of heme (protoporphyrin 
IX) dimers linked by the binding of the central iron of the first porphyrin ring to one of 
the propionic side chains of the reciprocating porphyrin.  An extended crystalline 
network is formed via hydrogen bonding between free propionic acid side chains 
followed by precipitation in solution.  The structure of hemozoin was first demonstrated 
	  
 
Figure 3. Chemical Structure of Hemozoin 
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by Pagola et al. from high-resolution synchrotron X-ray powder diffraction studies and 
was confirmed using isotope enriched Raman and IR spectroscopy.14,15  
 Upon regurgitation from the gut of the worm, hemozoin is released into the 
vasculature triggering an immune response by professional phagocytes.  Macrophages 
and neutrophils engulf the particulate, known as phagocytosis, in order to eradicate the 
foreign substance from the body.  Hz has long been considered an inert, detoxification  
end-product, but previous studies suggest that native hemozoin is capable of modulating 
host immunity.  Schwarzer and coworkers showed that phagocytosis of native hemozoin 
from P. falciparum disrupts the normal cellular function of human monocytes in 
vitro.16,17 The accumulation of native hemozoin in circulating monocytes (macrophages 
	  
	  
Figure 4.  Phagocytic funtion in response to extracellular microbial challenge. 
(Copywrite, Elsevier 2000)2 
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and neutrophils) inhibits normal phagocytic function by inducing oxidative stress and 
down regulating intercellular mechanisms that generate potent oxidative molecules used 
to defend against foreign invaders, namely reactive oxygen species (ROS) and reactive 
nitrogen species (RNS).18 (figure 4)  Furthermore, Hz has also been shown to induce 
lipid peroxidation via the non-enzymatic iron-catalyzed oxidation of polyunsaturated 
fatty acids (PUFAs) resulting in the formation of several potent, cytotoxic and 
immunosuppressive molecules including hydroxyeicosatetraenoic acids (HETEs)11,16,19 
and 4-hydroxy-2-nonenal (HNE).20,21 
 
 In human schistosomiasis, disease related pathology is primarily a result of the 
host's cell-mediated response to antigens released by entrapped parasite eggs in the 
liver.22 (figure 5) The schistosome egg-induced granulomatous response leads to severe 
inflammation, tissue eosinophilia, collagen deposition, and, ultimately, extensive hepatic 
	  
 
Figure 5.  Schistosomal hemozoin and parasitic egg deposition in Schistosomiasis 
pathology. 	  (Left)  Transmission electron micrograph of a S. mansoni hemozoin-laden kupffer 
cell. (Right)  Haematoxylin and eosin stained liver section of an embedded schistosome egg 
surrounded by granuloma-associated tissue. 
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fibrosis.22  Schistosomal pigment has long been observed in granulomatous liver tissue.  
In a recent study, the majority of hepatic granulomas observed in naturally infected 
Nectomys squamipes consisted of large macrophages filled with schistosomal Hz.23  
Consequently, Hz-mediated production of arachidonic acid (AA) metabolites, such as 
HETEs and HNE, are of significant interest in schistosomiasis since the role of Hz in the 
disease's pathogenesis remains largely unexplored. 
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Experimental 
 
Materials 
 S. mansoni infected Swiss-Webster mice were provided courtesy of Dr. Fred 
Lewis and the NIAID Schistosomiasis Resource Center (NIH-NIAID contract AI-30026) 
(Rockville, MD, USA).  Hydroxyeicosatetraenoic acid (HETE) standards were purchased 
from Cayman Chemical Company (Ann Arbor, MI, USA).  RPMI 1640, penicillin, and 
streptomycin were obtained from Cellgro Mediatech, Inc (Herdon, VA, USA).  
Arachidonic acid was obtained from Nu-Chek Prep Inc. (Elysian, MN, USA).  4-
hydroxy-2-nonenal (HNE) was purchased from Calbiochem (San Diego, CA, USA).  
Lipopolysaccharide (LPS) (E. coli 055:B5), chelex, sulfanilamide, N-(1-
naphthyl)ethylenediamine (NED), 2,6-lutidine, ethyl acetate, 2,6-di-tert-butyl-4-
methylphenol (BHT) and hemin chloride (Fluka-brand, >98%) were all purchased from 
Sigma-Aldrich (St. Louis, MO, USA).  All chemicals were used as received unless 
otherwise noted. 
 
β-hematin synthesis 
 β-hematin (BHz), the synthetic version of Hz, was synthesized via the method of 
dehydrohalogenation of hemin, as described by Bohle and Helms.  Briefly, in an inert 
atmosphere, hemin chloride (0.75 mmol) was dissolved in a minimal volume of 2,6-
lutidine and stirred vigorously for 10 min.  Upon complete dispersion, a 20 ml volume of 
50:50 anhydrous methanol:dimethylsulfoxide (v/v) was added to the hemin chloride 
solution.  The reaction vessel was then sealed, protected from ambient light, and allowed 
17	  
	  
to stand undisturbed for 3 months.  Upon completion, the reaction mixture was filtered 
and the resulting precipitate was washed exhaustively with excess methanol, 0.1 M 
sodium bicarbonate (pH 9.1) and deionized water.  After drying overnight at 150oC, the 
dark brown precipitate was alternately washed with deionized water and 0.1 M sodium 
bicarbonate (pH 9.1) until the supernatant was free of residual heme.  The identity of the 
final product was confirmed by x-ray diffraction (XRD), fourier-transform infrared 
spectroscopy (FT-IR), and scanning electron microscopy (SEM).  
 
SmHz Isolation 
 Adult schistosomes were obtained by mesenteric perfusion of mice 42 days after 
infection as previously described.  Freshly cultivated adult female worms were 
homogenized under sterile conditions in phosphate buffered saline (PBS, pH 7.4) using a 
standard 15 mL glass homogenizer.  The resulting homogenate was centrifuged twice at 
1000 x g for 60 s to remove worm tissue from the suspension.  The tissue pellet was 
removed and the resulting supernatant was centrifuged at 5500 x g for 2 h.  The resulting 
dark-brown pellet was resuspended in 5 mL of sterile PBS (pH 7.4) after vortexing and 
gentle sonication for 5 min.  SmHz content was quantitated as described by Sullivan et al. 
24. Briefly, SmHz was incubated with 20 mM NaOH + 2% SDS at room temperature for 
2 h to degrade the reciprocating iron-propionate linkages.  Heme content was determined 
from the absorbance at 400 nm (ε = 1 × 105 M-1cm-1) using an Agilent 8453 UV-Visible 
Spectrophotometer.   
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Native SmHz lipid extraction 
 The native SmHZ lipid component was extracted twice from 2.5 mg/mL native 
SmHZ in 25 mM chelexed-phosphate buffer (pH 7.4) using 1:1 (v/v) ethyl acetate.  The 
emulsion was vortexed 60 s and centrifuged 30 min at 5445 x g.  The organic layer was 
removed and evaporated under nitrogen.  The lipids were reconstituted in 1 mL of 
ethanol and stored at -80°C. 
 
In vitro Hz-mediated HETE production 
Purified native SmHZ, complete removal of lipids confirmed by NP-HPLC, was 
used in all experiments.  The reaction was performed by adding 5.32 mM AA to a 2 mL 
suspension of either SmHZ or BH (0.3 mg/mL) in 25 mM chelexed-phosphate buffer (pH 
7.4) for 4 h at 25°C.  Reaction products were extracted with ethyl acetate and stored in 
ethanol at -80°C. 
 
LC-MS/MS HETE identification.   
 HETE standards and lipid samples were dried under nitrogen and resuspended in 
acetonitrile/water (30:70), 10 mM ammonium carbonate and 0.1 M BHT prior to 
injection.  The LC-MS/MS analysis was performed on a Waters Acquity UPLC system 
(Waters, Milford, MA) connected to a Thermo Fisher Scientific, Waltham, MA) using a 
Thermo Hypersil Gold C18 column (1.9 µm, 2.1 x 150 mm).  LC conditions were as 
follows:  solvent A contained 10 mM ammonium carbonate in acetonitrile/water (10:90) 
and solvent B contained 10 mM ammonium carbonate in acetonitrile/water (10:90).  The 
following gradient program was used with a flow rate of 600 µL/min:  0-0.25 min, 30% 
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B; 0.25-9 min, linear gradient 30-45%; 9-10 min, 45% B; 10-10.50 min, linear gradient 
45-30% B; 10.50-17 min, 30% B.  Sample injection volume was 10 µL.  The following 
optimized parameters were used for the detection of analyte and internal standard:  N2 
sheath gas 36 psi; N2 auxiliary gas 20 psi; capillary temperature 300°C; source voltage 
3.8 kV; source current 100 µA; skimmer offset 0.00 V; capillary offset -44.00 V; tube 
lens offset -103.30 V; activation time 30 ms (MS), 50 ms (MS2); isolation width 1 m/z 
(MS), 2 m/z (MS2).  Data acquisition and quantitative spectral analysis was conducted 
using the Thermo-Finnigan Xcaliber software, version 2.0 Sur 1. 
 
LC-MS/MS chiral separation.   
 Normal phase LC (NP-LC) analysis was performed prior to chiral RP-LC-MS/MS 
in order to isolate HETE isomers for individual analysis.  The NP-LC was performed on a 
Waters 600 HPLC connected to a Waters 996 photodiode array (Waters, Milford, MA) 
using a Beckman Ultrasphere silica column (5 µm, 4.6 mm x 25 cm; Beckman Coulter, 
Fullerton, CA).  An isocratic gradient of 98.8% hexane, 1.2% isopropanol and 0.1% 
acetic acid was used at a flow rate of 1.00 mL/min.  HETE absorbance was detected at 
237 nm. 
 
Chiral-RP-LC-MS/MS.   
 The LC-MS/MS analysis was performed as before using a CHIRALPAK AD-RH 
column (5 µm, 2.1 mm x 150 mm; Chiral Technologies, Inc., West Chester, PA).  LC 
conditions were as follows:  solvent A contained 0.25% formic acid in acetonitrile/water 
(5:95) and solvent B contained 0.25% formic acid in acetonitrile/water (95:5).  The 
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following gradient program was used with a flow rate of 200 µL/min:  0-5 min, 50% B; 
5-20 min, linear gradient 50-100% B; 30-32 min, 50% B.  The following optimized 
parameters were used for the detection of analyte and internal standard:  N2 sheath gas 36 
psi; N2 auxiliary gas 20 psi; capillary temperature 300°C; source voltage 3.8 kV; source 
current 100 µA; skimmer offset 0.00 V; capillary offset -44.00 V; tube lens offset -103.30 
V; activation time 30 ms (MS), 50 ms (MS2); isolation width 1 m/z (MS), 2 m/z (MS2).  
Data acquisition and quantitative spectral analysis were conducted using Thermo-
Finnigan Xcaliber version 2.0 Sur 1. 
 
Cell Cultures 
 The RAW 264.7 murine macrophage cell line was cultured in RPMI 1640 
supplemented with 4 mM L-glutamine, 100 units/ml penicillin/streptomycin, and 10% 
(v/v) fetal bovine serum.  Before each experiment, the cells were incubated overnight at 
37oC in a 95% air / 5% CO2 atmosphere and washed once with sterile PBS (pH 7.4) 
before performing the appropriate experiment.  Cell viability was confimed by Trypan 
Blue exclusion. 
 
iNOS Inhibition Experiments 
 The inhibitory effects of (5-, 12-, 15-) HETE, HNE, and schistosomal Hz on LPS-
stimulated iNOS activity in RAW 264.7 cells was examined.  RAW 264.7 cells were 
plated at a density of 1 × 105 cells/well in 96-well culture plates and incubated at 37oC in 
a 5% CO2 atmosphere for ≥8 h.  To determine the inhibition by 5-, 12-, and 15-HETE, 
stock solutions of each isomer were prepared by evaporating each 100 µg vial to near 
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dryness under nitrogen and reconstituting in RPMI complete medium, paying close 
attention to keep ethanol concentrations below 0.5 % (v/v).  Concentrations were 
determined for each HETE stock solution by measuring the absorbance at 236 nm (ε = 
2.7 ± 104 M-1cm-1).    Cell cultures were treated with increasing concentrations of HETE 
(0-20 µM) and stimulated with LPS at a final concentration of 1 µg/mL.  To determine 
the inhibition by schistosomal Hz, stock solutions of 0.1 mg/mL schistosomal Hz, 0.1 
mg/mL βHz and 17.5 µM HNE were prepared in RPMI complete medium.  Cell cultures 
were treated with each stock solution and stimulated with LPS at a final concentration of 
1 µg/mL.  Cell cultures were incubated at 37oC in a 5% CO2 atmosphere and NO 
concentrations were determined after 24 h.  All iNOS inhibition experiments were 
performed in quadruplet and are reported as the average value with standard deviations.   
 
Nitric Oxide Measurements 
 Nitric oxide (NO) generation was determined by measuring the concentration of 
nitrite (NO2-), a stable NO oxidation product, in cell culture supernatants using the Greiss 
reaction.  After an incubation period of 24 h, the cell culture supernatant was removed 
and clarified by centrifugation at 13,200 x g for 5 min.  The reaction was performed by 
transferring 100 µl of the supernatant to a 96 well plate and adding 50 µl of 1% 
sulfanilamide in 5% phosphoric acid followed by 50 µl of 0.1% N-(1-
naphthyl)ethylenediamine (NED).  After incubation for 5 min at room temperature, the 
absorbance of the resulting azo complex was measured at 540 nm using a Bio-Tek 
Synergy HT Multidetection Microplate Reader.  NO2- concentrations were calculated 
using a NaNO2 standard curve. 
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Scanning electron microscopy   
 Dry purified SmHZ was suspended in ethanol, sonicated for 10 min, applied to a 
polished aluminum specimen mount, and dried at 25°C overnight.  Each sample was 
sputter-coated with gold for 20 s and imaged using a Hitachi S4200 scanning electron 
microscope at 5.0 kV accelerating voltage. 
 
Fourier Transform Infrared Spectroscopy (FT-IR) / X-ray Powder Diffraction (XRD) 
 Fourier transform IR spectroscopy was performed in a KBr pellet using an ATI 
Mattson Genesis Series FTIR spectrophotometer.  Powder X-ray diffraction scans were 
obtained on a Scintag X1 θ/θ automated powder diffractometer with a Cu target and a 
Peltier-cooled solid sate detector.  Samples were ground into a fine powder and placed 
evenly on a zero background Si (510) sample support.  All measurements were performed 
at a wavelength of 1.54056 Å with a step size of 0.02o in 2θ from 4o to 50o. 
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Results and Discussion 
 Schistosomal pigment (SmHZ) is typically found accumulated in resident tissue 
macrophages of the liver.  Adult worm pairs reside in the hepatic portal system of the 
host and regurgitate hemozoin and cellular debris into the surrounding vasculature.  Adult 
female worms exhibit a much heavier degree of pigmentation relative to males due to the 
nutritional demands of oogenesis (figure 6A).  Following perfusion of the hepatic portal 
vein in S. mansoni-infected Swiss Webster mice, adult female and male worms were 
separated, counted and homogenized to determine SmHZ burden per worm as previously 
described.25  On average, adult females were found to accumulate 1.729 ± 0.29 µg of 
hemozoin while the adult males were found to amass only 0.114 ± 0.07 µg per worm.  
Isolated SmHZ was purified and characterized using X-ray powder diffraction  
	  
	  
Figure 6 .  Hemozoin from S. Mansoni.  (A) Adult female (left) and male (right) S. mansoni 
laden with hemozoin.  (B)  SEM image of schistosomal hemozoin isolated from homogenized 
S. mansoni. (Copyright, Elsevier 2007) 
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(characteristic 2:1 intensity of the signature 2θ peaks at 7°: 21° and 24°) and Fourier 
transform infrared spectroscopy (1664 and 1211 cm-1 of C=O and C-O stretching) 
confirming a dimeric ferriprotoporphyrin IX aggregate identical to PfHZ and BH (Figure 
7).  While PfHZ and BH SEM images portray a biomineral of elongated rectangular 
crystals with well-defined crystal facets, SmHZ images depict the characteristic 
	  
 
Figure 7.  IR and XRD of HZ.	   	   (A) The presence of axial propionate linkages in 
HZ’s  dimeric ferriprotoporphyrin IX structure was confirmed using infrared 
spectroscopy showing the C-O stretching at 1211 cm-1 and C=O stretching at 1664 cm-
1.  (B) Characterization by powder x-ray diffraction (Cu Kα radiation) reveals the 2:1 
intensity of 2θ peaks at 7˚: 21˚ and 24˚.  Reduced peak distinction compared to BH in 
SmHZ pattern is attributed to limited sample size.  (Copyright, Elsevier 2007) 
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heterogeneous morphology and large size distribution often attributed to the extracellular 
environment of HZ formation in S. mansoni (figure 6B).13 
 The nature and function of the lipid environment surrounding the heme aggregate 
of native HZ is complex.  In a recent study, transmission electron microscopy (TEM) 
showed the localization of SmHZ at the hydrophilic-hydrophobic interface of lipid 
droplets in the S. mansoni gut lumen.26  Similarly, Pisciotta and coworkers extracted a 
suite of neutral lipids coating native HZ from the digestive food vacuole of P. 
falciparum.27  In both cases, the lipid extracts provided a competent scaffold for 
	  
	  
Figure 8. HETE-containing lipid coat of native SmHZ.  (A) Lipids were extracted from 
native SmHZ using ethyl acetate, blown dry under N2(g) and redissolved in RP-LC-MS/MS 
mobile phase.  All six hydroxylated fatty acid derivatives of arachidonic acid were identified 
(15-, 11-, 12-, 8-, 9- and 5-HETE).  Insert shows the representative chiral resolution for 15-
HETE (11.5 min. R and 14.5 min. S).  (B) Representative MS/MS fragmentation for 12-HETE.  
All isomers were confirmed using authentic standards and extracted ion profiles from MS/MS. 
(Copyright, Elsevier 2007)   
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hemozoin formation in vitro.  Polar hydroxylated fatty acids derived from arachidonic 
and linoleic acids have also been extracted from native PfHZ, as has the secondary 
oxidation product HNE.11,16,20  These compounds have been shown to be capable of 
significantly altering the function of macrophage cells during the course of malarial 
infection.   
 To investigate the presence of biologically active AA metabolites in native SmHZ, 
	  
Figure 9.  Extracted ion profile of SmHz lipid coat.  The identification of all six positional isomers of 
HETE in the SmHz lipid coat was achieved by extracting the characteristic MS/MS fragment masses of 
each isomer from the collected 319 m/z reverse-phase-LC-MS ions.  Individual isomers from the total 
ion chromatogram (A) of the SmHz lipid coat are shown:  (B) 15-HETE at 6.16 min., (C) 11-HETE at 
7.04 min., (D) 12-HETE at 7.19 min., (E) 8-HETE at 7.99 min., (F) 9-HETE at 8.10 min. and (G) 5-
HETE at 9.42 min.  Characteristic MS/MS fragments were confirmed using authentic HETE standards. 
(Copyright, Elsevier 2007) 
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the hydroxylated fatty acid component of native SmHZ was isolated and analyzed by 
liquid chromatography-tandem mass spectrometry (LC-MS/MS).  The identification of 
each HETE positional isomer peak was achieved using time dependent MS/MS in which 
the isobaric carboxylate [M-H]-, 319 m/z, precursor ion was trapped and subsequently 
fragmented to give product ions of each HETE isomer (figure 9).  All six HETE 
positional isomers derived from AA were observed in the SmHZ lipid extract, with the 
most abundant species being 15-, 12- and 5-HETE ([M-ROH]-: 219, 179 and 115 m/z, 
respectively) (figure 8).  In contrast to previous HETE identifications in hemozoin 
producing parasites16, the LC-MS/MS method presented herein is a marked advancement 
including MS/MS confirmation of all identified HETEs during separation and an 
increased instrument sensitivity reaching the femtomole range.  Such a limit of detection 
is especially important when working with the extracted lipids of limited native Hz 
samples, as is the case of S. mansoni yields from Swiss Webster mice (1 mg SmHZ/ 60 
mice).   
 Chiral purity of biologically derived hydroxylated fatty acids is typically 
attributed to the lipoxygenase (Lox) family with preference usually shown for S-stereo-
isomer products.28-35  In the absence of Lox, however, free radical-mediated peroxidation 
of AA can yield a racemic mixture of each hydroxylated isomer.  Given the presence of 
all six HETE isomers in the SmHZ lipid coat, additional chiral analysis was performed to 
examine the enantiomeric chiral analysis was performed to examine the enantiomeric 
distribution of the monohydroxy derivatives.  Chiral LC-MS/MS of the SmHZ lipid 
extract revealed an equivalent stereoselective distribution of all HETEs with the 
exception of 12-S-HETE (figure 10).  Based on integrated peak area, a 70:1 abundance of  
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12-S-HETE to 12-R-HETE was observed suggesting accumulation of enzymatically 
produced HETE.  This is in marked contrast to the equivalent stereoisomeric ratios 
observed for the 12-HETEs in the lipid coat of PfHZ.16  Previously, murine host 12-Lox 
activity has been described in the immunomodulation of schistosomiasis.26,36  Three types 
of murine 12-Lox (epidermal-, leukocyte- and platelet-type 12-Lox) have been reported, 
	  
 
Figure 10. Chiral-RP-LC-MS/MS of SmHz lipid coat.  R and S HETE enantiomers were separated 
using chiral-reverse-phase-LC-MS/MS (R- and S-HETE retention times shown in figure key).  Each 
HETE isomer was identified by its characteristic MS/MS fragment masses as determined from authentic 
HETE standards.  A 1:1 ratio was observed for all HETE enantiomers with the exception of 12-HETE 
which exhibited a 70:1 distribution of 12-S-HETE to 12-R-HETE. (Copyright, Elsevier 2007) 
.	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but none of these were observed in a recent proteomic analysis of gut contents from S. 
mansoni.26,36  In S. mansoni, only the activity of a 15-S-Lox has been reported, although 
sequence analysis of the partially sequenced S. mansoni genome suggests the possible 
presence of a 12-S-Lox gene.37  Regardless of the origin of the observed 12-S-HETE, the 
racemic mixture of all other HETE isomers is indicative of HZ-mediated lipid 
peroxidation of fatty acids. 
 In order to confirm the expected HZ-driven lipid peroxidation of fatty acids, in 
vitro, reactions of AA incubated with either purified SmHZ or BH were performed under 
aerobic conditions.  The resultant oxidized lipids were extracted and characterized by RP- 
and chiral-LC-MS/MS.  Relative to AA controls, both purified SmHZ and BH produced 
significant quantities of the six HETE positional hydroxylation isomers, with 15- and 5-
HETE as the most prominent (figures 11-13).  These findings are in good agreement with 
earlier literature concerning the reactivity of both purified PfHZ and BH.11,38   
	  
 
Figure 11.  Hemozoin-mediated lipid peroxidation of arachidonic acid.	   	   Oxidation studies by 
incubation of 0.3 mg/mL BH or SmHZ with 5.32 mM AA were conducted.  The hydroxylated fatty acid 
isomers 15-, 11-, 12-, 8-, 9- and 5-HETE were identified in the reactions’ lipid extracts using RP-LC-
MS/MS.	  (Copyright, Elsevier 2007)	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Upon subsequent chiral analysis, the positional HETE isomers were separated with a 
stereoselective ratio of nearly 1, suggesting no preferential stereochemical orientation of 
the substrate during oxidation.  As expected, the stereoselective bias for 12-S-HETE seen 
in the native SmHZ lipid coat was absent in the reaction of either purified SmHZ or BH 
	  
 
 
Figure 12.  Extracted ion profile of HETEs from the BH-AA reaction.	   	   All six 
positional isomers of HETEs were extracted and confirmed by MS/MS from the BH-
AA reaction.  (Copyright, Elsevier 2007)   
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with AA.  Taken together, these results demonstrate that SmHZ mediated peroxidation of 
PUFAs is the likely source for the enantiomeric population of observed HETE isomers in 
the lipid coat.  
 Lipid metabolites have been shown to elicit immunomodulatory effects ranging 
from impairment of both PMA-stimulated oxidative burst and nitric oxide (NO) 
production in macrophages to altering endothelial cell permeability and initiating 
	  
 
Figure 13.  Extracted ion profile of HETEs from the SmHZ-AA reaction. 	  All six 
positional isomers of HETEs were extracted and confirmed by MS/MS from the 
SmHZ-AA reaction. (Copyright, Elsevier 2007) 
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chemotaxis.16,39,40  Investigation of the HETE isomers’ individual effects on macrophage-
like cell function following LPS challenge revealed that the predominate 5-, 12- and 15-
S-HETEs impaired NO production in a dose-dependent manner (figure 14A).  12-S-
HETE was the most potent inhibitor of iNOS, attenuating NO production by 50%.  The 
immunosuppressive activity of native SmHZ’s hydroxylated fatty acids suggest that 
phagocytosis of native SmHZ by resident macrophages may partially disrupt the innate 
immune response.  In fact, further study revealed a 25% reduction in NO production in 
lipid-coated SmHZ-laden macrophages relative to control experiments, implicating native 
SmHZ as a biologically active agent (figure 14B).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  
Figure 14.    Impact of native SmHZ and components on iNOS activity.  (A) RNS 
production in macrophage cells monitored following treatment with increasing 
concentrations of (●) 15-, (■) 12- and (▲) 5-S-HETE by the Griess assay.  (B) Cells 
were treated with 0.1 mg/mL BH or SmHZ, as well as 40 µM 15-S-HETE or HNE.  
The activity of cells stimulated with LPS was used as a control. (Copyright, Elsevier 
2007) 
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Conclusion 
 The lipid coat of native SmHZ is a complex mixture of both neutral lipids and 
PUFA peroxidation products.  Herein, the composition of the arachidonate metabolites 
has been determined to consist of an enantiomeric mixture of all positional hydroxylated 
isomers with 15-, 12- and 5-HETE as the dominant species.  These findings are consistent 
with HZ-mediated non-enzymatic lipid peroxidation of host arachidonate.  Additional 
chiral analysis revealed an accumulation of a biologically derived 12-S-HETE of an 
unknown origin.  When the immunosuppressive activity of native SmHZ and its major 
HETE components was examined in macrophage-like cells, iNOS activity was impaired.  
Further exploration of this unique biomineral’s composition and its ability to modulate 
host immunity is crucial in developing a better understanding of the possible role of 
hemozoin in the host-pathogen interactions involving S. mansoni. 
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CHAPTER III 
 
METABOLIC IMPACT OF 4-HYDROXYNONENAL ON MACROPHAGE 
FUNCTION AND ACTIVATION 
 
 
Introduction 
 4-hydroxynonenal (HNE) is an α,β-unsaturated aldehyde that is emerging  as a 
biochemical marker of oxidative stress in many diseases such as Parkinson's disease, 
Alzheimer's disease, atherosclerosis, malaria and even obesity.1-6  During cellular 
oxidative stress, HNE is formed by means of membrane lipid peroxidation which is 
initiated by the surrounding reactive oxygen species.8   HNE is a highly reactive 
electrophile that covalently modifies DNA and protein resulting in genetic mutations, 
altered cellular function and ultimately cell death.9   
 HNE is formed as a secondary oxidation product of the peroxidation of cellular 
membrane-rich fatty acids including arachidonic and linoleic acids.  The primary 
reactants for HNE include the amino acid residues of cysteine, histidine and lysine and 
typically occurs by the formation of Michael adducts and/or Schiff bases at available 
basic amino acid residues.  HNE modification of cellular proteins and enzymes results in 
wide range of cellular dysfunction including protein and nucleic acid synthesis, 
mitochondrial and cellular respiration as well as specialized cell functions such as 
oxidative burst in neutrophils and macrophages.10-12   
 In the case of specialized cell function, professional phagocytes such as 
macrophages engulf microbial intruders and effectively kill and eradicate the foreign 
bodies.  During this process, NADPH oxidase  translocates to the phagolysosome to 
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provides the antimicrobial superoxide (O2-) substrate for a plethora of reactive oxygen 
and nitrogen species (ROS, RNS).13  Macrophages are equipped with endogenous 
antioxidant mechanisms that prevent excessive lipid peroxidation buildup within the cell  
while exogenous HNE exposure has been shown to dramatically impair macrophage 
function including: inducible nitric oxide synthase (iNOS), phorbol ester stimulated 
oxidative burst, and phagocytosis.11,14 
 To investigate the metabolic impact of HNE exposure on macrophage function 
	  
 
 
 
Figure 15 .  Schematic of a Cytosensor Microphysiometer 	  (A)  Low-buffered running 
medium, (B) peristaltic pumps, (C) Teflon debubbler membrane, (D) LAPS sensor cup, cell 
culture immobilization membrane and custom MMP sensorhead/plunger, (E) online Ag/AgCl 
reference electrode.  
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and activation, we employed a multianalyte microphysiometer (MMP) that 
simultaneously measures multiple cellular metabolites in real-time.15  The MMP is based 
on a core cell-based assay platform known as the Cytosensor microphysiometer.7,15-17  
The Cytosensor microphysiometer was designed to use a light-addressable potentiometric 
sensor (LAPS) to measure extracellular acidification rates (ECARs) in cultured cells due 
to the build-up of acidic by-products.18-20  Recently, incorporation of oxygen, glucose and 
lactate electrodes into the sensor head platform have provided an effect means of 
concurrently measuring each extracellular analyte fluctuation using ion-selective and 
enzyme coated platinum electrodes via the amperometric detection of molecular oxygen  
and hydrogen peroxide, respectively.15   
 The Cytosensor microphysiometer operates by flowing a low-buffered medium in 
a series of cycles across cells seeded between two polycarbonate membranes (figure 16).  
The instrument consists of four channels, each with independent peristaltic pumps, a 
Teflon membrane debubbler, sensor chamber and reference electrode (figure 15).  The 
flow cycles are composed of a pump on (flow) and pump off (stop-flow) phase.  
Experimental data points are collected in real-time and changes during a stop-flow phase 
measures the rate of consumption or production of each analyte based on the 
decrease/increase due to consumption or excretion of analyte.  Data analysis is based on 
the changes in peak height or area under the peak which allows for monitoring metabolic 
changes over a finite period time.16 
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  This study is dedicated to understanding the metabolic changes imposed on 
macrophages  upon exposure to HNE.  Multianalyte microphysiometry was used to 
monitor real-time perturbations in acidification rate, lactate production and oxygen 
consumption.  RAW 264.7 murine macrophages were exposed to increasing 
concentrations of HNE at various time intervals to assess both concentration and 
temporal dependence of HNE toxicity and immunosuppression.  Following online HNE 
treatment, macrophage cells were activated with phorbol myristate acetate (PMA) to 
measure the corresponding change in metabolism upon initiation of oxidative burst.  The 
	  
	  
Figure 16.  Schematic of the fully assemble MMP sensor head.7  The LAPS sensor cup is 
fully submerged in low-buffered medium. with the cells immobilized between two 
polycarbonate porous membranes (3 µm).  Running medium flows through the 3 µL 
measurement chamber .  Analyte measurement and acidification measurements are performed 
in real-time.  
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results of this study explicitly show that HNE is a potent modulator of cellular 
metabolism that readily inhibits PMA-induced oxidative burst in macrophages.  The 
complex nature of HNE toxicity on macrophage function  and resulting 
immunosuppression of oxidative burst suggests that covalent modification of downstream 
signaling proteins such as protein kinase C (PKC) are intimately involved with 
impairment of NADPH oxidase activity. 
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Experimental 
 
Materials 
 Glucose oxidase (GOx, aspergillus niger), lactate oxidase (LOx, pediococcus), 
bovine serum albumin (BSA, Fraction V, 96%), glutaraldehyde (25 wt.% solution in 
water), and 3-aminophthalhydrazine (luminol) were purchased from Sigma Aldrich (St. 
Louis, MO).  RPMI 1640 low-buffered medium and all Cytosensor consumable materials 
were obtained from Molecular Devices (Sunnyvale, CA).  Nafion (perfluorosulfonic acid-
PTFE copolymer, 5% w/w solution) and platinum wire (0.13 mm, 0.5 mm and 1.5 mm) 
was obtained from Alpha Aesar.  4-hydroxynonenal (HNE), phorbol-12-myristate-13-
acetate (PMA) and the polyclonal anti-PKC (protein kinase C) antibodies were obtained 
from Calbiochem.  Fetal bovine serum was purchased from Atlanta Biologicals.  
Penicillin/streptomycin was purchased from Mediatech.  The mouse macrophage cell 
line, RAW 264.7 was obtained from the American Type Culture Collection. 
 
Multianalyte Microphysiometer Enzyme-based Electrodes 
 Cytosensor microphysiometer plunger heads were purchased from Molecular 
Devices, Inc. and modified for multianalyte measurement by constructing multiple 
platinum electrodes at the face of the plunger head (see figure 18).  Platinum wires were 
inserted into predrilled holes through the plunger head and sealed with a non-conductive 
white epoxy, polished with emery paper using a customized brass jig, and further 
polished with 1 µm diamond paste until flush with the plunger head surface.  The enzyme 
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film solutions consisted of 5 mg GOx and 0.1 mg LOx dissolved in a 10% BSA/PBS 
solution and were cross-linked with either 5 µL or 1 µL of 25 % glutaraldehyde solution, 
respectively.  Each enzyme film solution was prepared fresh and a minimal amount 
applied to the platinum electrode.  Enzyme films were allowed to dry for 30 min and 
prior to use, GOx and oxygen electrodes were coated with a minimal amount of 5% 
Nafion (w/w). 
 Glucose measurements were obtained during each experiment but were excluded 
from the results analysis due to the lack of appreciable signal change throughout the 
study. Lactate measurements were performed  indirectly by amperometrically measuring 
changes in hydrogen peroxide (+0.6 V) generated at the lactate oxidase (LOx) membrane 
on platinum electrode.  Changes in oxygen consumption were measured 
amperometrically (-0.45 V) and all electrode potentials were set versus a Ag/AgCl 
reference electrode.  Acidification rates were measured by traditional operation of the 
Cytosensor instrument as specified by the manufacturer.   
 
MMP Instrument Operation 
 The MMP was operated under standard Cytosensor microphysiometer conditions 
utilizing an 60-s flow cycle and a 60-s stop-flow cycle.  Prior to insertion of the modified 
plunger head, the MMP was conditioned by flowing low-buffered RPMI 1640 media 
through the system for 30 min.  Sensor chambers and Teflon debubblers were preheated 
for 30 min in order to ensure an optimum temperature (37oC) for data collection.  After 
complete conditioning, the modified sensor head was placed in the sensor chamber and 
cells (5 x 105 RAW 264.7 cells/capsule cup) were allowed to equilibrate for 20 min.   
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MMP Metabolic Data Collection and Interpretation 
 Electrochemical measurements were allowed to run for 50 minutes prior to the 
addition of HNE (0-300 µM) and/or PMA (16 µM) in the running medium.  For each 
experiment, metabolic measurement of four individual and independent RAW 264.7 cell 
populations were collected with the following treatment conditions each lane: (1) 
untreated control population; (2) 20 minute HNE exposure (1 mL); (3) 40 minute HNE 
exposure (2 mL); and (4) 60 minute HNE exposure (3 mL).  Oxidative burst 
measurements following HNE treatment were collected after a 30 minutes equilibration 
period of fresh medium.  Oxidative burst was initiatiated by introducing 16 µM PMA for 
10 minutes (0.5 mL).  Data points were collected in real-time and extracted from stop-
flow measurements at 2 minute intervals (2 min = 1 cycle).   
 The extracellular acidification rate (ECAR) data was recorded in normal operating 
order by the Cytosensor microphysiometer.  Electrochemical measurements for lactate 
and oxygen were collected on either a CHI 103 multipotentiostat (CH Instruments, 
Austin, TX) or an in-house custom quad-multiplexed multipotentiostat.  ECAR data was 
plotted as -µV/s versus time (s).  The changes in oxygen consumption and lactate 
production were quantified by calculating the change in signal (nA) during stop-flow 
events.  Each cycle measurement was plotted as singal increase/decrease (nA) versus 
time (2 min).  Baseline correction for all measurements was performed by linear-fit 
correction from the linear extension of the initial equilibration period.  The linearized 
metabolic curves were normalized to 1 with experimental changes represented by percent 
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of control. Overall relative changes in metabolism were presented as the average 
percentage value of 10 cycles upon introduction of fresh medium. 
 
Cell Culture 
 The adherent mouse macrophage cell line, RAW 264.7, was maintained in 
continuous culture with RPMI 1640 medium, supplemented with 10% (v/v) fetal bovine 
serum and 100 U/mL penicillin/streptomycin in a 5% CO2, 37oC atmosphere.   
 
Inhibition of RAW 264.7 ROS Production with HNE 
 RAW 264.7 cells were plated overnight in 6 well plates at a density of 4E6 cells 
per well.  The cells were washed once with sterile PBS followed by incubation with HNE 
(0-50 µM)  for 3 hours.  After HNE treatment, the cells were washed once with cold PBS 
and treated with 100 nM PMA in PBS for 5 minutes to initiate oxidative burst.  After 5 
minutes, the supernatant was removed and transferred to luminometer cuvettes.  Upon 
addition of 50 µL of 1.0 mM luminol, luminescence was measured for ten seconds using 
a Moonlight 3010 luminometer. 
 
Cell Treatment with HNE for Western Blot Analysis  
RAW 264.7 mouse macrophage cells were plated overnight at a density of 4E6 
cells per 100 mm dish. The following day, the cells were treated with 10 mL of 35 µM 
HNE prepared in media and incubated at 37oC, 95% humidity and 5% CO2. Once the 
allotted time (0, 0.5, 1.0, 1.5, 2.0, 2.5 and 3.0 hours) had passed, the samples were 
removed from the incubator, washed 3 times with cold PBS and treated with 400 µL of 
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cold lysis buffer (25 mM Tris-HCl, pH 7.4, 0.25 mM sucrose, 2.5 mM EDTA, 2.5 mM 
DTT). After five minutes of rapid agitation, the samples were scrapped, pipetted to 
microcentrofuge tubes, and gently sonicated with a probe sonicator. Next, the samples 
were centrifuged for 45 minutes at 13,200 RPM. The supernatant was collected and 
protein content was analyzed using the Biorad DC assay kit. 
 
Western Blot Analysis of Cell Lysates 
All samples examined by gel electrophoresis/western blotting, were prepared at a 
2 µg/µL concentration and run on Novex 10 % Tris-glycine gels (Invitrogen) followed by 
transfer to polyvinylidene difluoride (PVDF) membranes (Invitrogen). After complete 
transfer, the membranes were blocked for 1 hour or overnight with 5 % nonfat dry milk 
dissolved in Tris-Tween buffer (TBST) composed of 25 mM Tris-HCl, pH 7.4, with 137 
mM NaCl, 2.7 mM KCl, and 0.01 % Tween 20, TBST. PKC obtained from the cells was 
detected by incubation with rabbit polyclonal anti-protein kinase C (α/β) (371-388) 
antibodies (diluted 1:230 in 5% nonfat dry milk) for 2 hours at room temperature. 
Standard PKC βII was detected by incubation with rabbit polyclonal anti-PKC βII 
primary antibody (diluted 1:100 in 5 % nonfat dry milk) for 2 hours at room temperature. 
For both, incubation with the primary was followed by TBST washing and incubation 
with a horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (diluted 
1:2000 in 5 % nonfat dry milk) for 1 hour at room temperature. HNE adducted proteins 
were detected by incubation with mouse monoclonal anti-HNE primary antibody (diluted 
1:500 in 5 % nonfat dry milk) for 2 hours at room temperature, followed by incubation 
with a horseradish peroxidase-conjugated goat anti-mouse secondary antibody (diluted 
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1:2000 in 5 % nonfat dry milk) for 1 hour at room temperature. An ECL Western blotting 
analysis detection system (Amersham Biosciencees) was used to visualize the bands in all 
cases. 
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Results and Discussion 
A Simple Model of Cellular Metabolism 
 In general, cellular metabolism is a complex network of small molecule fluxes 
that varies among organisms, cell type and in some cases, individual cells of the same 
phenotype.  Glycolysis accounts for the majority of metabolic output within a cell due to 
the requisite need of energy in the form of ATP.  Glycolysis occurs by means of two 
major pathways: (1) anaerobic conversion of glucose into lactic acid and (2) aerobic 
glucose metabolism via the Krebs' tricarboxylic acid (TCA) cycle (figure 17).21,22  The 
TCA cycle is the dominant mode of ATP production within a normal resting cell.  The 
	  
	  
	  
Figure 17.  Cellular Energy Metabolism (Copyright, MDPI 2009)7  
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TCA cycle ultimately oxidizes glucose to carbon dioxide and water.  In the case of 
anaerobic glucose metabolism, glycolysis proceeds to form pyruvate followed by an 
oxygen-independent conversion to lactic acid  by means of LDH.  Measurement of 
cellular oxygen consumption (aerobic) and lactate production (anaerobic) in concert 
allows for metabolic changes to be accurately assessed for each independent energy 
pathway.  By integrating both an oxygen sensor and a lactate sensor with the acidification 
LAPS sensor, a more complex metabolic profile of energy metabolism can be achieved.   
  
MMP Sensor Head Design and Operation 
 To achieve simultaneous measurements for key metabolites for each glycolytic 
	  
	  
Figure 18.  Modified MMP sensor head.  (A) Fully constructed MMP sensor head with embedded 
platinum wire electrodes.  (B)  Schematic of the MMP sensor head media pathway.  (C)  Schematic 
representation of direct and enzymatic electrochemical detection of glycolysis metabolites.  
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pathway, enzyme-immobilized membranes were utilized for the indirect measurement of 
glucose and lactate concentrations within the cell chamber (figure 18).  Both GOx and 
LOx convert their respective substrate to hydrogen peroxide which is then detected 
amperometrically by applying a +0.6V potential to oxidize two hydrogen peroxide 
molecules to water and oxygen.  The oxygen electrode directly (-0.45V) reduces 
molecular oxygen but with the aid of a negatively charged Nafion membrane to eliminate 
background noise.   
 
Metabolic Impact of HNE on Steady State Macrophage Metabolism 
 The complex biochemical interactions that occur between cellular 
macromolecules and HNE results in a variety of cellular perturbations including 
disruption of cytoskeletal integrity, impairment of mitochondrial respiration, inhibition of 
DNA, RNA and protein synthesis as well as impairment of specialized cellular functions 
such as oxidative burst in professional phagocytes.11,14,23  During periods of oxidative 
stress, the surrounding cellular environment is exposed to errant reactive oxygen species 
that can potentially interact with membrane-derived unsaturated fatty acids resulting in 
the accumulation of HNE at significant concentrations. To date, malaria-derived  
hemozoin-laden monocytes were measured to have the highest intracellular HNE 
concentration at 23 pmols/106 cells (~46 µM).10   
 Real-time monitoring of lactate, oxygen and acidification rate changes for live 
cells is an attractive tool for assessing perturbations to cellular energy metabolism as a 
result of outside stimuli.  To explore the metabolic impact HNE imposes on energy 
metabolism, RAW 264.7 murine macrophages were subjected to HNE treatment in a 
concentration and time dependent experimental design.    In each experiment, RAW 
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264.7 cells were seeded at a density of 3E5 cells per polycarbonate cell capsule 4 hours 
prior to assembly of the full MMP instrumental setup.  The following time course was 
performed for each experiment: (A) 60 minute equilibration period; (B) 0, 20, 40 or 60 
minute HNE exposure (0, 50, 100, 200 or 300 µM); (C) 30 minute stabilization period. 
 Changes in cellular steady state metabolism were determined by taking the 
average of the last five measurements during the stabilization period (figure 19).  The 
change in metabolic output for each sensor was measured in real-time and is represented 
	  
	  
Figure 19. Conversion of Raw MMP Measurements to Metabolic Rate Values.  (A) Raw LP data for 
20 min exposure to 300 µM HNE.  (B) Scatter plot of stop-flow peak height measurements.  (C) Linear 
normalized rate plot.  *(Green arrows): start of HNE treatment; (Red arrows): start of fresh media; 
(Blue): Average LP Rate Value (n=5). 
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as acidification rate (AR), lactate production rate (LPR) and oxygen consumption rate 
(OCR). 
  
Table 1.  HNE-induced Metabolic Rate Changes in Steady State Macrophage Metabolism 
	  
Acidification	  Rate	  (AR)	  
HNE	  Concentration	  
Exposure	  Time	   50	  µM	   100	  µM	   200	  µM	   300	  µM	  
Control	   103.90	  ±	  0.73%	   103.15	  ±	  5.72%	   101.46	  ±	  3.66%	   102.98	  ±	  2.01%	  
20	  min	   83.80	  ±	  1.14%	   72.43	  ±	  8.16%	   58.65	  ±	  5.46%	   47.19	  ±	  6.12%	  
40	  min	   65.21	  ±	  1.01%	   59.57	  ±2.68%	   50.22	  ±	  3.65%	   32.53	  ±	  3.74%	  
60	  min	   53.67	  ±	  0.47%	   49.43	  ±	  4.40%	   41.91	  ±	  0.79%	   21.54	  ±	  3.08%	  
	  
Lactate	  Production	  (LP)	  Rate	  
HNE	  Concentration	  
Exposure	  Time	   50	  µM	   100	  µM	   200	  µM	   300	  µM	  
Control	   99.63	  ±	  0.22%	   101.83	  ±	  0.53%	   100.96	  ±	  4.18%	   101.74	  ±	  7.54%	  
20	  min	   81.56	  ±	  0.63%	   68.87	  ±	  2.94%	   55.11	  ±	  5.19%	   45.76	  ±	  10.12%	  
40	  min	   58.21	  ±	  0.54%	   64.90	  ±2.07%	   48.28	  ±	  6.93%	   17.92	  ±	  10.05%	  
60	  min	   42.48	  ±	  0.75%	   45.77	  ±	  2.21%	   25.99	  ±	  9.13%	   10.75	  ±	  6.31%	  
	  
 
 The experimental results displayed in table 1 and figures 20 and 21 clearly show 
that macrophage metabolism is disrupted by HNE exposure in both a concentration and 
time-dependent manner.  The effect of HNE on acidification rates  was a linear dose-  
 
 
 
Oxygen	  Consumption	  (OC)	  Rate	  
HNE	  Concentration	  
Exposure	  Time	   50	  µM	   100	  µM	   200	  µM	   300	  µM	  
Control	   99.78	  ±	  0.80%	   100.25	  ±	  0.29%	   103.26	  ±	  4.62%	   100.01	  ±	  1.17%	  
20	  min	   80.93	  ±	  0.19%	   87.71	  ±	  0.92%	   90.77	  ±	  1.38%	   72.72	  ±	  3.64%	  
40	  min	   83.18	  ±	  0.23%	   93.59	  ±0.31%	   89.61	  ±	  0.96%	   60.25	  ±	  7.80%	  
60	  min	   59.42	  ±	  2.39%	   90.00	  ±	  0.46%	   86.24	  ±	  1.37%	   12.68	  ±	  5.98%	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Figure 20.  3D Composite of HNE-treated Steady State Macrophage Metabolism.  (top) AR rate 
changes, (middle) LP rate changes, and (bottom) OC rate changes.  Rate changes are representative of 
final metabolic rate post-HNE exposure. 
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dependent reduction in extracellular acidification with all HNE treatment eliciting a 
reduction in AR.  At the highest concentration (300 µM) and longest exposure (60 min), 
the steady state macrophage acidification rate dropped to 21.54 % of baseline.   
 In terms of anaerobic metabolism, lactate production rates experienced a similar 
dose-dependent response in terms of both concentration as well as exposure.  As with AR 
metabolism, lactate production rates followed a concentration-dependent recession with a 
reduction in LO rate to 10.75% of baseline after 60 minutes of exposure to 300 µM.  The 
	  
 
Figure 21. HNE Effects on Macrophage Metabolism as a Function of Concentration.  (A) AR rate 
chages, (B) LP rate changes, and (C) OC rate changes. 
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LO rate profile suggests that lactate response is slightly more sensitive to HNE in a 
concentration-dependent manner.   
 On the contrary, OC rates proved to be much more resilient to HNE toxicity as a 
whole.  At HNE concentrations  of 0-200 µM, oxygen consumption remained stable at 
>80% OC rates with very little discrimination between exposure times.  At the highest 
concentration (300 µM), a dramatic drop in oxygen consumption was observed for each 
treatment in a time-dependent manner.  Macrophage oxygen consumption was essentially 
attenuated (12.7%) after 60 minutes of exposure to 300 µM HNE  and is indicative of cell 
death.  This same conclusion can be made for both LOR (10.7%) and AR (21.5%) at high 
concentration and exposure.  Cell death was confirmed by carefully removing the 
polycarbonate membrane and visual inspection with trypan-blue using a standard  
microscope. 
 Overall, the metabolic rate data suggests that RAW 264.7 macrophages are 
susceptible to HNE toxicity as concentrations as low as 50 µM with an exposure time of 
20 minutes.  The MMP data is collected in a series of stop-and-go flow cycles at intervals 
of 60 s flow/60 s stop-flow.  With a flow rate of 100 µL/minute, a total volume of 1 mL 
can be assigned to each 20 minute intervals of exposure.  This would represent a total 
molar HNE flux of 50-900 nmols for the lowest and highest concentration and exposure 
time, respectively.  Each cell capsule is seeded with 3E5 cells and the fully assembled 
MMP sensor chamber amasses  30% of the culture area.  This equates to a toxicity profile 
that spans 50-900 nmols per 104 cells. 
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Metabolic Rate Profile PMA-induced Oxidative Burst in RAW 264.7 Macrophages 
  To examine the energy metabolism of oxidative burst during macrophage 
activation,  RAW 264.7 cells were treated for 10 minutes (5 cycles) with 16 µM phorbol-
12-myristate-13-acetate (PMA) and metabolic changes were monitored thereafter for 30 
minutes (figure 22A).  PMA is a small organic molecule that mimics intracellular 
diacylglycerol and acts through activation of protein kinase C (PKC).24  PKC is an 
enzyme that is a key intermediate for many cellular signaling processes.25,26  PKC 
functions by means of intracellular phosphorylation of serine and threonine resides.26  
PMA initiation of oxidative burst begins with phosphorylation of cytosolic p47phox 
followed by membrane assembly of multicomponent NADPH oxidase.25  
 Immediately following PMA exposure,  a dynamic change for each metabolic rate 
with lactate production exhibiting the most dynamic change (+30.2%) followed by AR 
	  
 
Figure 22.  PMA-stimulated Macrophage Metabolic Response.  (A) Normalized metabolic rate curves 
showing PMA introduction at t = 140 min.  (B)  Average metabolic response of each cellular metabolic 
rate.  Determined from three independent experiments (n = 4). 
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rate (25.8%) and OC rate (+16.1%) (figure 22B).  An overall increase in metabolic 
activity is to be expected due to the energy dependent assembly and activation of 
NADPH oxidase.  PMA activation of RAW 264.7 cells displayed a gradual but 
pronounced increase in AR rate immediately upon exposure.  When PMA was removed 
from the medium, AR rate was sustained at an elevated rate constant for >2hr.  Unlike the 
gradual increase observed for AR rate, the LP rate displayed a more pronounced temporal 
increase reaching a maximum LP rate after 50 miniutes post PMA treatment.  The 
increased LP rate is directly related to an increase in anaerobic respiration.    In the case 
of oxygen consumption, an increase in OC rate would be expected due to NADPH 
oxidase conversion of extracellular molecular oxygen to superoxide.  PMA-induced 
oxidative burst of RAW 264.7 cells displayed a sharp increase in oxygen consumption 
initially (t=0-10 min) that peaked after PMA was removed from the running media.  A 
gradual decrease in OC rate was observed for the remainder of the experiment but 
remained elevated above baseline after 2 hours.   
 Collectively, these results paint a detailed metabolic picture of macrophage 
cellular respiration upon activation of NADPH oxidase by PMA.  Immediately following 
PMA introduction, macrophage AR, LP and OC rates rapidly increases due to increased 
demand for requisite cellular energy (ATP) and molecular oxygen.  Following removal of 
PMA from the running media, a pronounced initial decline in oxygen consumption was 
observed most likely due to the absence of NADPH oxidase activation which was 
followed by down regulation  of the enzyme.  In regards to energy metabolism, removal 
of PMA from the medium stabilizes elevated AR and LP rates but without an appreciable 
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decline (>2hr).  The "primed" macrophage appears to retain an elevated state of cellular 
respiration and energy metabolism before returning to a normal state metabolism. 
 
Metabolic Impact of HNE exposure on PMA-induced RAW 264.7 Oxidative Burst 
 HNE has been shown to impair and modulate key innate immune  function in 
professional phagocytic cells, including oxidative burst and inducible nitric oxide 
synthase (iNOS).11,12,27,28  Consequently, the exact mode by which HNE inhibition of 
oxidative burst occurs lies within the complex protein network involved in NADPH 
oxidase assembly and activation. To investigate HNE inhibition of PMA-induced 
 
Table 2.   HNE Effect on Metabolic Rate Changes in PMA-induced Oxidative Burst 
 
Acidification	  Rate	  Change	  
HNE	  Concentration	  
Exposure	  Time	   50	  µM	   100	  µM	   200	  µM	   300	  µM	  
Control	   18.73 ± 1.97% 17.74 ± 6.98% 30.54 ± 7.20% 36.00 ± 3.07% 
20	  min	   10.78 ± 2.00% 40.87 ± 11.30% 27.59 ± 6.76% 0.67 ± 8.95% 
40	  min	   9.69 ± 2.13% 45.03 ± 6.98% 8.04 ± 5.14% -21.40 ± 4.35% 
60	  min	   8.33 ± 2.00% 32.29 ± 6.18% 16.07 ± 3.12% -23.46 ± 4.17% 
	  
Lactate	  Production	  Rate	  Change	  
HNE	  Concentration	  
Exposure	  Time	   50	  µM	   100	  µM	   200	  µM	   300	  µM	  
Control	   16.36 ± 5.89% 39.15 ± 1.77% 29.22 ± 4.85% 36.21 ± 8.74% 
20	  min	   25.84 ± 1.25% 21.31 ± 7.92% 7.00 ± 7.06% -10.89 ± 14.61% 
40	  min	   48.00 ± 3.07% 38.77 ± 3.29% -10.71 ± 9.74% -47.84 ± 11.18% 
60	  min	   38.94 ± 2.00% -25.54 ± 2.48% -38.30 ± 3.55% -48.45 ± 8.01% 
	  
Oxygen	  Consumption	  
HNE	  Concentration	  
Exposure	  Time	   50	  µM	   100	  µM	   200	  µM	   300	  µM	  
Control	   30.93 ± 2.67% 5.67 ± 0.52% 17.31 ± 5.75% 10.63 ± 1.93% 
20	  min	   1.91 ± 0.28% -5.29 ± 2.18% 4.91 ± 2.48% 4.70 ± 4.28% 
40	  min	   -12.33 ± 0.61% -2.67 ± 0.53% 1.26 ± 1.77% -21.49 ± 9.48% 
60	  min	   -15.81 ± 2.90% -2.28 ± 0.64% 0.39 ± 1.96% -61.65 ± 8.74% 
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oxidative burst in macrophages, RAW 264.7  cells were treated with HNE (0-300 µM) at 
variable exposure times (0-60 min) followed by PMA activation.  Each experiment was 
performed using the following experimental design: (1) 60 min equilibration period 
(Media); (2) 0-60 min HNE exposure (0-300 µM HNE in media); (3) 30 minute 
equilibration period; (4) 10 min 16 µM PMA exposure; (5) 50 min equilibration period.  
Metabolic rate changes were determined immediately following PMA exposure an 
average of five sequential data points, and are presented as percent to corrected baseline. 
 While MMP measurements do not directly measure NADPH oxidase generation 
of superoxide, the metabolic changes that are elicited by PMA activation provide a 
unique metabolic fingerprint for comparison against HNE-treated samples.  As illustrated 
in table 2 and figures 23 and 24, pretreatment of RAW 264.7 cells  with HNE suppresses 
PMA-induced metabolic changes to some degree and induces a negative response for 
each metabolite at high concentration and exposure time.  
 The metabolic treads for PMA activation as a function of concentration are not 
nearly as straight-forward in comparison to the metabolic trends of the HNE toxicity 
analysis above.  Looking first at metabolic rates at low HNE concentrations (50 and 100 
µM), metabolic measurements revealed only minor changes in metabolic response with 
respect to HNE exposure time.   For cells exposed to 100 µM HNE, PMA stimulation 
immediately increased AR at a 2-fold higher AR rate as compared to control.  At higher 
HNE concentrations (200 and 300 µM), AR rates start to drop off and terminate with  
negative AR rate changes.  For LP rate changes, a steep regression into negative LP rates 
begins at the 100 µM-60min data point and terminates at 300µM-60min with a 50% 
reduction in lactate signal.  At these concentrations, PMA treatment at 16 µM for 5 cycles  
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(8 nmols) severely attenuates anaerobic metabolism.  The corresponding OC rates for 
	  
 
Figure 23.  3D Composite of HNE effects on macrophage oxidative burst metabolism (top) AR 
rate changes, (middle) LP rate changes, and (bottom) OC rate changes.  Rate changes are 
representative of deviation change as compared to steady state values. 
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high HNE concentrations remain relatively stable without any distinguishable 
fluctuations, excluding the 300 µM-40min and 300 µM-60min time points.   
 Collectively, the results of MMP PMA-stimulation measurements show that 
typical metabolic increases upon PMA activation of NADPH oxidase are severely 
impaired at concentrations greater than 200 µM HNE and issue a negative metabolic 
effect at high concentrations.  While the effects of HNE on steady state  macrophage 
metabolism occurs in a concentration and time-dependent manner, changes in PMA-
activation metabolism were not consistent with respect to cellular metabolism as a whole.  
	  
 
Figure 24. HNE Effects on Macrophage Oxidative Burst Metabolism as a Function of 
Concentration 
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This leads one to believe that inhibition of oxidative burst by HNE is not simply 
inactivation of the superoxide generating enzyme but the result of changes in downfield 
intracellular signaling pathways which can lead to incomplete assembly. 
 
HNE Inhibition of Oxidative Burst in RAW 264.7 Cells Assessed by Luminol 
 To directly determine NADPH oxidase HNE inhibition, RAW 264.7 cells (4E6 
	  
Figure 15.  HNE Inhibition of PMA-induced ROS.  (A) Concentration-dependent (0- 
50 µM HNE) and (B) Time-dependent (0-3 hr, 35 µM HNE) inhibition of ROS 
generation assessed by luminol enhanced chemicluminescence.   
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cells) were treated with increasing concentrations (0- 50 µM) of HNE for 3 hrs prior to 
PMA-stimuation and luminol detection of extracellular reactive oxygen species (ROS).  
RAW 264.7 cells exhibited a concentration-dependent inhibition of ROS with an EC50 
value of 18.4 ± 1.2 µM (figure 25A).  This value is consistent with previously published 
values for murine macrophages which reported an EC50 value of 27 µM.29  To examine 
the temporal effects of HNE on PMA-induced ROS generation, RAW 264.7 cells were 
treated with 35 µM HNE for 0-3 hours and subsequently activated with 16 µM PMA to 
determine the change in ROS generation.  The results indicate a time-dependent 
inhibition of macrophage oxidative burst with a 50% reduction of ROS generation after 1 
hour (figure 25B).  ROS generation was further reduced to 20% following 2 hours of 
exposure and completely attenuated after 3 hrs.  The potent ability of HNE to inhibit ROS 
generation combined with the time-dependent sensitivity of HNE oxidative burst suggests 
that other cellular proteins and enzymes are involved. 
 
Formation of HNE Adducts to Protein Kinase C (PKC) 
 The potent ability of HNE to inhibit ROS generation in a dose and time-
dependent manner combined with the HNE-induced disruption of metabolic rates before 
and after PMA stimulation suggest that the inhibitory effects of HNE originate from 
downstream signaling or in concert with multiple protein signaling pathways.  To 
investigate the inactiviation of the well documented downstream signaling protein26, we 
explored the ability of HNE to chemically modify protein kinase C (PKC) in cultured 
RAW 264.7 macrophages.   
 Inhibition of PKC activity has been shown to occur an HNE levels as low as 10 
µM.30  Once activated, PKC functions by phosphorylating a number of downstream 
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substrate proteins that regulate multiple cellular processes including oxidative burst.26  Of 
the eleven known isoforms of PKC, the βII isoform has been implicated in the 
phosphorylation of p47 phox which ultimately results in the translocation of the cytosolic 
components of NADPH oxidase to the cellular membrane.  Therefore, inhibition of PKC 
would prevent the assembly of NADPH oxidase.  Since HNE readily forms covalent 
protein modifications, it is plausible that the observed oxidative burst inhibition is due to 
formation of HNE adducts on key amino acid residues of PKC.  While there are several 
potential protein targets that may be affected by HNE adduction, the connection between 
increased levels of HNE and decreased PKC activity provides an intriguing target of 
interest. 
 To examine the possiblity of HNE adduct formation on intracellular PKC, RAW 
264.7 cell lysates were isolated from samples treated in a time-dependent manner (0-3 hr) 
with 35 µM HNE and examined for the presence of HNE adducts on PKC by western 
blot analysis.  In figure 26, a reproducible PKC-labeled band for each untreated time 
	  
 
Figure 26. Western blot analysis of HNE-modified PKC from cell lysates.  (A) PKC protein 
bands labeled with monoclonal anti-PKC antibody, (B) 35 µM HNE-treated PKC protein bands 
labeled with monoclonal anti HNE antibody. 
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point suggesting cellular integrity remained consistent from 0-3 hrs.  After the initial 0 hr 
time point, HNE-adduct formation became increasingly prominent as a function of 
exposure time (figure 26).  The temporal component associated with HNE protein 
adduction has also been documented for other proteins such as myoglobin which 
indicated that sterically available basic amino acid residues were requisite for HNE-
protein adduct formation.  The propensity of HNE to form intracellular protein adducts  
with PKC in a temporal and concentration-dependent manner clearly demonstrates the 
complex experimental approach needed to identifying the key proteins, enzymes and 
other cellular signaling molecules involved HNE impairment of macrophage oxidative 
burst. 
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Conclusions 
 The highly reactive electrophile HNE is a potent fatty acid oxidation byproduct 
which has been implicated in a wide range of diseases as a marker of oxidative stress.10  
The main mode of cellular HNE toxicity  results from covalent adduction and 
modification of susceptible proteins and enzymes.31  This body of work set out to 
examine the metabolic impact of HNE exposure on macrophage function and activation.  
Using RAW 264.7 macrophages coupled to a modified multianalyte microphysiometer 
(MMP), three key metabolic species associated with cellular respiration and energy 
metabolism (oxygen, lactate, and acidification) were monitored in real-time.  Upon 
introduction of HNE in the running media, each metabolic rate displayed a dose and 
time-dependent reduction in comparison to control experiments.   
 When treated with 16 µM PMA to induce oxidative burst, a significant increase in 
metabolic rate was observed for each metabolite suggesting a significant total increase in 
cellular metabolism as a result of activation.  RAW 264.7 cells treated with HNE  prior to 
PMA activation exhibited  a reduction in the expected metabolic flux at low 
concentrations/exposure (0-100 µM) and was completely attenuated or cytotoxic at high 
concentrations/exposure of HNE (200-300 µM).   The one exception was observed for 
lactate production rates at 100 µM HNE exposure that displayed a 2-fold increase in LP 
rate, independent of time.  Luminol-based studies of PMA-treated cells showed a dose 
and time-dependent inhibition of ROS production (oxidative burst).  The discrepancies in 
temporal effects associated with lactate measurements and luminol experiments suggest 
that other requisite signaling proteins/enzymes are involved in oxidative burst inhibition.  
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Western blot analysis of PKC from RAW 264.7 cell lysates exposed to 35 µM HNE 
displayed a time dependent sensitivity to HNE adduct formation.   
 The results of this study clearly show that HNE exposure reduces energy 
metabolism of RAW 264.7 macrophages in a concentration and time-dependent manner.  
At high concentrations of HNE (>100 µM), PMA-induced metabolic flux was completely 
attenuated and even cytotoxic at pretreatment concentrations of 300 µM.  In addition, a 
new signaling protein target of interest (PKC) was indentified which leads to speculation 
of the exact nature of HNE toxicity.    In order to understand the dynamics of HNE 
inhibition of oxidative burst, a further analysis of HNE interaction with the NADPH 
oxidase signaling pathway is needed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
68	  
	  
References 
 
1. Grune, T.; Siems, W. G.; Schonheit, K.; Blasig, I. E. Int J Tissue React 1993, 15, 
 145-50. 
 
2. Montine, T. J.; Huang, D. Y.; Valentine, W. M.; Amarnath, V.; Saunders, A.; 
 Weisgraber, K. H.; Graham, D. G.; Strittmatter, W. J. J Neuropathol Exp Neurol 
 1996, 55, 202-10. 
 
3. Sayre, L. M.; Zelasko, D. A.; Harris, P. L.; Perry, G.; Salomon, R. G.; Smith, M. 
 A. J Neurochem 1997, 68, 2092-7. 
 
4. Selley, M. L. Free Radic Biol Med 1998, 25, 169-74. 
 
5. Soares, A. F.; Guichardant, M.; Cozzone, D.; Bernoud-Hubac, N.; Bouzaidi-Tiali, 
 N.; Lagarde, M.; Geloen, A. Free Radic Biol Med 2005, 38, 882-9. 
 
6. Uchida, K.; Toyokuni, S.; Nishikawa, K.; Kawakishi, S.; Oda, H.; Hiai, H.; 
 Stadtman, E. R. Biochemistry 1994, 33, 12487-94. 
 
7. Eklund, S. E.; Thompson, R. G.; Snider, R. M.; Carney, C. K.; Wright, D. W.; 
 Wikswo, J.; Cliffel, D. E. Sensors 2009, 9, 2117-2133. 
 
8. Marnett, L. J.; Riggins, J. N.; West, J. D. J Clin Invest 2003, 111, 583-93. 
 
9. Hill, B. G.; Dranka, B. P.; Zou, L.; Chatham, J. C.; Darley-Usmar, V. M. Biochem 
 J 2009, 424, 99-107. 
 
10. Poli, G.; Schaur, R. J. IUBMB Life 2000, 50, 315-21. 
 
11. Carney, C. K.; Schrimpe, A. C.; Halfpenny, K.; Harry, R. S.; Miller, C. M.; 
 Broncel, M.; Sewell, S. L.; Schaff, J. E.; Deol, R.; Carter, M. D.; Wright, D. W. J 
 Biol Inorg Chem 2006, 11, 917-29. 
 
12. Schwarzer, E.; Kuhn, H.; Valente, E.; Arese, P. Blood 2003, 101, 722-8. 
 
13. Forman, H. J.; Torres, M. Mol Aspects Med 2001, 22, 189-216. 
 
14. Neely, M. D.; Amarnath, V.; Weitlauf, C.; Montine, T. J. Chem Res Toxicol 2002, 
 15, 40-7. 
 
15. Eklund, S. E.; Taylor, D.; Kozlov, E.; Prokop, A.; Cliffel, D. E. Anal Chem 2004, 
 76, 519-27. 
69	  
	  
16. Eklund, S. E.; Cliffel, D. E.; Kozlov, E.; Prokop, A.; Wilkswo, J.; Baudenbacher, 
 F. Analytica Chimica Acta 2003, 496, 93-101. 
 
17. Eklund, S. E.; Snider, R. M.; Wikswo, J.; Baudenbacher, F.; Prokop, A.; Cliffel, 
 D. E. J. of Electroanalytical Chemistry 2006, 587, 333-339. 
 
18. Hafner, F. Biosens Bioelectron 2000, 15, 149-58. 
 
19. McConnell, H. M.; Owicki, J. C.; Parce, J. W.; Miller, D. L.; Baxter, G. T.; Wada, 
 H. G.; Pitchford, S. Science 1992, 257, 1906-12. 
 
20. Wille, K.; Paige, L. A.; Higgins, A. J. Receptors Channels 2003, 9, 125-31. 
 
21. Owicki, J. C.; Parce, J. W. Nature 1990, 344, 271. 
 
22. Owicki, J. C.; Parce, J. W.; Kercso, K. M.; Sigal, G. B.; Muir, V. C.; Venter, J. 
 C.; Fraser, C. M.; McConnell, H. M. Proc Natl Acad Sci U S A 1990, 87, 4007-11. 
 
23. Schrimpe, A. C.; Wright, D. W. Chem Res Toxicol 2009. 
 
24. Mosior, M.; Newton, A. C. J Biol Chem 1995, 270, 25526-33. 
 
25. Greene, N. M.; Williams, D. S.; Newton, A. C. J Biol Chem 1995, 270, 6710-7. 
 
26. Newton, A. C. J Biol Chem 1995, 270, 28495-8. 
 
27. Schwarzer, E.; Turrini, F.; Ulliers, D.; Giribaldi, G.; Ginsburg, H.; Arese, P. J Exp 
 Med 1992, 176, 1033-41. 
 
28. Siems, W. G.; Capuozzo, E.; Verginelli, D.; Salerno, C.; Crifo, C.; Grune, T. Free 
 Radic Res 1997, 27, 353-8. 
 
29. Dianzani, C.; Parrini, M.; Ferrara, C.; Fantozzi, R. Cell Biochem Funct 1996, 14, 
 193-200. 
 
30. Schwarzer, E.; Arese, P. Biochim Biophys Acta 1996, 1316, 169-75. 
 
31. Vila, A.; Tallman, K. A.; Jacobs, A. T.; Liebler, D. C.; Porter, N. A.; Marnett, L. 
 J. Chem Res Toxicol 2008, 21, 432-44. 
 
 
70	  
	  
CHAPTER IV 
 
NOVEL HAIRPIN DNA-COATED GOLD NANOPARTICLES FOR THE 
DETECTION OF METASTATIC MELANOMA 
 
 
 
Introduction 
 In the United States alone, one in three people are at risk of developing some form 
of cancer during their lifetime.1  With more than one million new cases in the US this 
year alone, skin cancer has become the prevalent diagnosis among all forms of cancer.1  
Melanoma is one of the fastest growing forms of diagnosed cancer in the United States 
with nearly 70,000 new cases in the US this year alone.1  Early detection of melanoma is 
essential for a positive outcome, given that nearly 80% of all cases diagnosed early result 
in a ten year survival rate.3  This highlights the need for new and sensitive diagnostic 
approaches capable of providing early and accurate assessment.   
 The most common method for diagnosis of malignant melanoma is histological 
examination which is invasive, highly interpretable, and requires a significant 
accumulation of cancerous cells.4  Once metastasis occurs, screening methods are 
ineffective because of melanoma heterogeneity and a lack of accumulation of melanoma 
cells in the peripheral blood.  Current techniques for diagnosing late stage melanoma 
utilize both antibody-assisted protein detection and reverse transcription-polymerase 
chain reaction (RT-PCR) to identify proteins and protein expression targets associated 
with metastatic melanoma.5-8  Both techniques have proven to be effective in identifying 
melanoma metastasis but suffer from tedious sample processing and conflicting results.8,9 
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 Several melanoma markers have been indentified to date which specifically detect 
tumor cells derived from the melanocyte lineage.8  The most widely studied melanoma-
specific marker is the expression of the tyrosinase gene.4,5,10  Tyrosinase (TYR) is an 
enzyme involved in the conversion of tyrosine to melanin during melanin biosynthesis 
(figure 27).2 TYR is expressed by normal melanocytes, melanoma cells, as well as some 
forms of brain and colon cancers.2  The cell specificity of TYR gene expression makes it 
an ideal target for detecting metastatic melanoma in the blood, lymph nodes or other 
organs.11 
 Gene expression refers to the mRNA signaling process that is responsible for 
translation and assembly of the intact proteins.  RT-PCR is  considered the gold standard 
for identification and quantification of cellular mRNA and has been used for a variety of 
studies to identify TYR mRNA in melanoma patients with conflicting results.7,8,12   RT-
PCR is a technique that proceeds via (1) reverse transcriptase-dependent conversion of 
	  	  
	  
	  
Figure 27.  Tyrosinase-mediated Melanin Biosynthesis.  (left) Assymetrical melanoma lesion.  
(right)  Melanin biosynthetic pathway. (Copyright, FASEB 1991) 2 
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RNA into complement DNA (cDNA), (2) PCR amplification of the ensuing cDNA and 
(3) detection of  amplification products in real-time.  While a powerful technique with 
excellent sensitivity, RT-PCR requires extensive sample preparation, terminal cell lysis 
for RNA harvesting, and laborious reaction optimization.  Additionally, spatial and 
temporal information of mRNA-specific processes are not available. 
 Several live cell imaging probes and techniques have been developed for 
intracellular mRNA imaging and include linear oligonucleotide probes, hairpin 
oligonucleotide probes (or molecular beacons) and Förster resonance energy transfer 
reporters.13-16  While effective, these mRNA imaging techniques require additional 
reagents for  delivery into the cytoplasm by means of electroporation17, chemically-
mediated membrane permeabilization17,18 and/or cationic cell-penetrating peptides.13  
Additionally, free oligonucleotide imaging probes, such as molecular beacons, are highly 
succeptible to endogenous nuclease-degradation, and readily exhibit false-positive signals 
using artifical transfection methods.17,19-21 
 The use of nanotechnology coupled with traditional biodiagnostics has recently 
shown to be beneficial in developing noninvasive diagnostic platforms.22,23  Current 
advances in oligonucleotide-functionalized gold nanoparticles (AuNP)  have proven to 
circumvented the potential pitfalls of traditional molecular beacon imaging by 
eliminating the need for invasive transfection agents.24,25  Additionally, hypothesized 
steric bulk effect associated with the gold nanoparticle scaffold reduced intracellular 
nuclease degradation by an order of magnitude as  compared to free molecular beacons.25   
  Applications of nanotechnology to the biodiagnostic field hold promise for the 
development of new platforms capable of improving current melanoma detection.  
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Herein, we present a new hairpin DNA functionalized gold nanoparticle that positively 
identifies tyrosinase mRNA in both melanoma cell lines and primary tumor cultures.  A 
multiplexed analysis of multiple melanoma markers was explored by incorporation of 
two additional melanoma marker inspired probes and a standard housekeeping gene 
probe for investigating intracellular gene expression in multiple melanoma cell lines. 
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Experimental 
 
Materials and Methods 
 All chemicals were used as received unless otherwise noted.  The human cell 
lines, SK-MEL-28 and HEp-2, were obtained from the American Type Culture 
Collection (ATCC).  Additional human melanoma cell lines used in profiling experiments 
(Wm115, MeWo and HS-294T) were kindly provided by Donna Hick, Vanderbilt Ingram 
Cancer Center (VICC).  15 nm gold colloid solutions were obtained from Ted Pella, Inc 
(Redding, CA).  Syto-13 nuclear dye (Sy13), Sytox Green viability dye (SxG), Mito-
tracker Orange (MO) and sterile nuclease free phosphate buffered saline without MgCl2 
and CaCl2 (PBS, pH 7.4) were obtained from Invitrogen Corp (Carlsbad, CA).  Bovine 
deoxyribonuclease I (DNase I) was purchased from Promega (Madison, WI).  Molecular 
beacons (MB), unmodified oligonucleotides, custom oligonucleotides and PCR primers 
were purchased from Biosearch Technologies, Inc (Novato, CA).  All other chemicals 
were purchased from Sigma Aldridge, Inc (St. Louis, MO). 
 
Hairpin Oligonucleotides 
 The mRNA recognition sequences used for this study were as follows: (TYR Rec. 
Seq) 5'-attgtgcatgctgctttgag-3'; (S100β Rec. Seq) 5'-cagtagtaaccatggcaaca-3'; (MIA Rec. 
Seq) 5'-aggtttcagggtctggtcct-3'; (βactin Rec. Seq) 5'-ggagttgaaggtagtttcgt-3' and  
(MisMatch Rec. Seq) 5'-gtattggaagtcgttcgatgatcactcgc-3' or 5'-ggagttgaaggtagtttcgt-3'.  
Each recognition sequence was extensively BLAST searched to confirm either target 
specificity (100% overlap) or non-specificity (MM rec seq) with minimal overlap with 
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other potential human gene transcripts (<70%).  Prior to use, thiol-terminated 
oligonucleotides were subjected to 0.1 M dithiolthreitol (DTT) reduction of the 5' thiol 
moiety.  Excess reducing agent was removed by 3K molecular weight centrifugal 
filtration and washed three times with PBS (Amicon Ultracel 3K, Millipore).  Freshly 
reduced oligonucleotides were stored in 1X Tris EDTA (TE) buffer (pH 8) at -80oC until 
use.   
 
hAuNP Sysnthesis 
 Briefly, a 10 nM solution of citrate-stabilized AuNPs (15 nm) was incubated with 
2 µM freshly reduced DNA overnight at room temperature and protected from light.  
After the initial loading period, the resulting solution was buffered to 10 mM phosphate 
buffer (PB, pH 7) with 0.1% Tween-20 and vortexed for 30 sec.  Three successive 
aloquots of 5M NaCl were added to the buffered solution in 2hr intervals until a final 
concentration of 0.3 M NaCl was achieved.  The resulting hAuNPs were purified by three 
centrifugation washes (30 min, 17,000 x g) and stored in phosphate buffered saline (PBS, 
pH 7.4) at 4oC. 
 
Cell Viability 
The cell viability dye Sytox Green was employed for all flow cytometric analysis.  
Trypan blue exclusion was utilized for all other experiments. 
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Cell Culture 
 SK-MEL-28, Wm115, MeWo, HS-294T and HEp2 cells were cultured in high 
glucose DMEM growth medium supplemented with 10% fetal bovine serum (FBS), 100 
units of penicillin/streptomycin and 2% L-glutamine.  Primary cell cultures were 
maintained in RPMI 1640 growth medium supplemented with 10% fetal bovine serum 
(FBS) , 100 units of penicillin/streptomycin and 2% L-glutamine.  Phenol-red free RPMI 
1640 supplemented with 5% FBS was used for all live-cell fluorescence experiments.  
Co-culture experiments were performed by adding equal cell volumes (e.g. 5e5 Mels / 
5e5 HEp2, total cell count = 1e6) to either a 35mm Mattek microwell dish or well plates 
and allowed to adhere to the surface > 4hrs before treatment with hAuNPs in complete 
growth medium. 
 
Dynamic Light Scattering (DLS) 
 All DLS measurements were performed on a Malvern Zetasizer Nano ZS.  
Particle measurements were performed at a concentration of 1 nM in water and measured 
in triplicate.  To determine the size of 'open' TYR hAuNPs, a 1 nM solution of TYR 
hAuNPs was treated with 1 µM TYR recognition complement and incubated at 37oC for 
2 hours prior to measurement.   
 
Absorption and Fluorescence Measurements 
 Absorption measurements were performed on an Agilent 8453 diode-array 
spectrophotometer.  The concentration of AuNPs and hAuNPs was determined by 
measuring the absorbance at 520 nm (ε = 3.64 x 108 M-1cm-1).26  The emission spectrum 
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of 'open' TYR hAuNPs was obtained by treating a 5 nM solution of TYR hAuNPs (PBS, 
0.1% Tween-20) with 1 µM TYR recognition complement and incubating at 37oC for 2 
hours.   Fluorescence spectra of the resulting 'open' TYR hAuNP solution was generated 
on a Cary Eclipse Fluorescence Spectrophotometer by exciting at 620 nm and measuring 
the emission from 650 to 750 nm.  Target selectivity assays and DNase I susceptibility 
measurements were performed using a Bio-Tek Synergy HY multidetection fluorescent 
microplate reader using a 590/35 excitation filter and a 645/40 emission filter. 
 
hAuNP Target Selectivity 
 To measure selectivity of the hAuNP probe, TYR hAuNPs (1 nM, PBS, 0.1% 
tween-20) were titrated with increasing concentrations of TYR recognition complement 
(0-1 µM) and MM DNA (0-1 µM) keeping a total volume of 200 µl.  The resulting 
solutions were sealed, protected from light and allowed to hybridize for 2 hours at 37oC.  
Fluorescence intensities were measured as described above and plotted as a function of 
complement concentration.  Signal to noise was determined by the ratio of TYR target 
fluorescence versus MM background fluorescence. 
 Specificity of additional probe designs for S100β, MIA and β-actin were 
performed in a similar manner by incubating each hAuNP (1 nM) with 1 µM target 
complement and 1µM MM DNA.  As before, solutions were sealed, protected from light 
and allowed to incubate for 2 hr at 37oC.  Signal to noise was determined by the ratio of 
target fluorescence versus MM background fluorescence. 
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DNase I Susceptibility 
 To determine hAuNP suceptibility to nuclease degredation, TYR hAuNPs and 
free molecular beacons were analyzed.  The following tyrosinase-specific molecular 
beacon was employed: (TYR MB Seq) 5'-Cy5-cgacgattgtgcatgctgctttgagcgtcg-BHQ3-3'.  
TYR hAuNP solutions (2.2 nM) and TYR MBs (200 nM) were diluted in nuclease 
reaction buffer (100 mM Tris-HCl, 5 mM MgSO4, 1 mM CaCl2, pH 8.0) and 100 µl 
aliquots of each added to a 96-well black wall microplate.  Both TYR hAuNPs and TYR 
MBs were treated with 10 µl of either: 1 U/mL DNase (excess, endpoint determination), 
1 U/L DNase (optimum), or PBS (baseline) and transferred immediately to a preheated 
fluorescent microplate reader (37oC).  Fluorescence output for each well was monitored 
every 300 seconds for 3 hours to generate degradation progress curves for each sample.   
DNase susceptibility was evaluated by the slope of the initial linear region. 
 
Scanning Confocal Microscopy 
 Cells were grown in 35 mm Mattek dishes and kept at approximately 50% 
confluence.  Cells were treated with 0.5 nM hAuNPs in complete media.  After the 4 hr 
loading period, the cells were washed twice with PBS and fresh medium was added to the 
dish.  After incubating for 12 hours at 37oC, the media was removed and fresh phenol-red 
free media added to the dish.  For images with a green nuclear stain, cells were treated 
with 25 nM Syto-13 for 15 minutes prior to imaging.  For images with an orange 
mitochondrial stain, cells were treated with 5 nM Mito-Tracker Orange for 15 minutes 
prior to imaging.  All images were captured on a Zeiss LSM 510 Meta inverted confocal 
microscope with identical optical settings for each session.  Fluorescent images were 
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captured using the following excitation lasers and corresponding filter sets: Syto13 
nuclear stain (488nm; bandpass 505-530nm) and quasar 670 hAuNP probe (633nm; 
longpass 650nm). 
  
Flow Cytometry 
 Cells were grown in 6 well plates (1e6 cells/well) and treated with 0.5 nM 
hAuNPs as described above.  After a 12 hr hybridization period, cells were lifted from 
the plate with 0.05% trypsin-EDTA, washed twice with cold PBS, resuspended in 500 µl 
of cold phenol-red free media containing 5% FBS and stored on ice until analyzed.  The 
addition of Sytox Green (50 nM) to each sample was used to assess cellular integrity and 
tolerance of hAuNPs.  Samples were analyzed on a Custom Becton Dickinson five-laser 
LSRII analytical flow cytometer using forward and side scatter focusing.  Sytox Green 
and Cy5 emissions were monitored simultaneously for 10,000 events and a mean 
fluorescence for each fluorescent signal was recorded.   
 
Reverse-transcription polymerase chain reaction (RT-PCR) 
 To confirm the presence, absence and comparative expression levels of each 
melanoma marker, RT-PCR was performed for all cell lines.  Cellular mRNA was 
extracted from each cell line using the RNeasy Mini Kit (Qiagen) according to the 
manufacturers protocol.  Purified mRNA was quantified by UV-Vis.  RT-PCR was 
performed using a Rotor-Gene Q real time cycler (Qiagen) and QTaq One-Step qRT-PCR 
SYBR Kit (Clontech).  Briefly, 15 ng (5 µL) of RNA from each cell line was reverse-
transcribed and amplified in a 25 µL reaction volume with the following components: 
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12.5 µL of 2X One-Step qRT-PCR Buffer plus SYBR, 0.5 µL of 50X QTaq DNA 
Polymerase Mix, 0.4 µL of 60X qRT Mix, 200 nM forward and reverse primers, and 
DNase/RNase free water.  The following primers were employed: TYR Forward (5'-
ttggcagattgtctgtagcc-3'), TYR Reverse (5'-aggcattgtgcatgctgctt-3'), S100β Forward (5'-
atgtctgagctggagaaggccat-3'), S100β Reverse (5'-actgcctgccacgagttctttgaa-3'), MIA 
Forward (5'-catgcatgcggtcctatgcccaagctg-3'), MIA Reverse (5'-
gataagctttcactggcagtagaaatc-3'), β-Actin Forward (5'-gcgggaaatcgtgcgtgacatt-3') and β-
Actin Reverse (5'-gatggagttgaaggtagtttcgtg-3').  Cycling conditions were as follows: 45 
min at 48oC, 3 min at 95oC, followed by 40 cycles each of 1 min at 55oC and 2 min at 
72oC.    5 µL of the TYR and β-actin PCR products were subjected to electrophoresis on 
a 1.2% agarose E-gel (Invitrogen) and visualized under UV light. The expected sizes of 
the PCR products were 289 bp (tyrosinase) and 232 bp (β-actin).   For profiling 
experiments, Ct values were process based on the comparative Ct method where the 
relative transcript level of each target gene was calculated according to the equation 2-ΔCt, 
where ΔCt is defined as Ct target gene - Ct βactin gene. 
 
hAuNP Melanoma Profile Experiments 
 hAuNP profile experiments were carried out in a similar manner in comparison to 
flow cytometric analysis as described above.  The human melanoma cell lines SK-MEL-
28, Wm115, MeWo and HS-294T as well as the non-melanoma cell line HEp2 were 
employed for all profiling experiments.   Cells were plated at a concentration of 1E6 cells 
per well in 6 well plates and treated with 0.25 nM melanoma target hAuNPs / 0.25 nM 
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βactin hAuNPs simultaneously for 4 hrs followed by a 12 hr hybridization period and 
analyzed by flow cytometry. 
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Results and Discussion 
 AuNPs offer unique physical and optical properties as potential probes in that 
they readily enter cells without the need for transfection agents, are non-cytotoxic and 
can efficiently quench fluorescent molecules when in close proximity to the particle 
surface.24,25,27-30  To circumvent the inherent pitfalls associated with current mRNA 
detection methods such as RT-PCR and molecular beacons, an mRNA imaging probe 
combining gold nanoparticles with current molecular beacon-based technologies, termed 
hairpin DNA-coated gold nanoparticles (hAuNP), was developed.   
 This modular nanoscale construct consists of a core gold nanoparticle (15 nm 
	  
 
Figure 28. Schematic of hAuNP Design 
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diameter) with covalently attached thiol-terminated DNA hairpin oligonucleotides. 
(figure 28)  Each DNA hairpin beacon is constructed of a 5’ hexane thiol linker 
covalently attached to a 10 thymine extension followed by a 20 base recognition hairpin 
loop complementary to its mRNA target.   The recognition loop is flanked on each side 
by five complementary bases to create the hairpin secondary structure.  When the hairpin 
DNA is in the closed position, a 3’ modified fluorescent dye is quenched by its proximity 
to the AuNP surface.    In the presence of its target complement, hybridization of the 
twenty base recognition loop releases the fluorescent molecule from its closed state to an 
open fluorescent state (figure 29).  
	  
 
Figure 29. hAuNP mRNA Detection Scheme 
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 To test this modular mRNA probe, we designed the recognition loop to be 
complementary to the common melanoma gene target tyrosinase.  When designing the 
recognition loop, extensive BLAST search analysis was performed to ensure specificity 
to its cellular mRNA target.   The oligonucleotide loading for each particle was 
determined by subjecting a 10 nM solution of hAuNPs to dithiolthreitol reduction to 
reduce the Au-thiol bonds and precipitate the gold particles.  The oligonucleotide-to-
particle ratio was determined to be ~90 DNA strands per hAuNP.  Dynamic light 
scattering (DLS) confirmed the conformational change of hairpin DNA on the surface of 
the AuNP resulting in an average diameter of 23.1 ± 1.2 nm post synthesis and 27.6 ± 0.8 
nm in the presence of excess complementary DNA.  Absorption spectroscopy confirmed 
that the characteristic 522nm plasmon peak remains unchanged after covalent attachment 
of DNA to the particle surface.  The fluorescent spectral properties of the 3’ fluorophore, 
Quasar 670, were fully retained with an excitation maximum of 647 nm and emission 
maximum of 667 nm when reacted with complement.   
 To determine the specificity and robustness of the TYR hAuNP probe, specificity 
of tyrosinase hAuNPs (TYR hAuNPs) was determined by titration with a 20 base 
complement versus a 20 base non-complementary oligonucleotide (both having an equal 
GC content) for 2 hr at 37oC (figure 30). As expected, TYR hAuNPs showed good 
specificity with a 3 fold increase in signal for the proper TYR complement when 
compared to mismatch DNA.   
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 With any intercellular fluorescent oligonucleotide probe, endogenous nuclease 
degradation is of particular concern and often results in a high background and/or false 
positives.17    The stability of TYR hAuNPs against nuclease degradation was determined 
by comparison of TYR hAuNPs (2.2 nM) and TYR molecular beacons (TYR MB, 200 
nM) when treated with DNAse I (0.1 U/L) at 37oC for 3 hr.  Over time, TYR hAuNPs 
proved to be far superior with a 12.5 fold decrease in nuclease degradation (0.097 
nmol/min) as compared with TYR MBs (1.22 nmol/min) (figure 31).  Such a decrease in  
 
	  
Figure 30.  TYR hAuNP Target Selectivity Assay.  TYR hAuNPs (1 nM) treated with 
increasing amounts of TYR recognition complement (black) and MM complement (red).  
The ratio of TYR target fluorescence versus MM background fluorescence yielded a S/N =3 
at complement concentrations > 250 nM. 
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nuclease susceptibility makes these probes much more attractive than free MBs within 
the cytoplasm of the cell.   
 To examine the utility of TYR hAuNPs as intracellular mRNA probes, the SK-
MEL-28 melanoma cell line was used as a testing platform due to their inherent elevated 
tyrosinase gene expression.31 SK-MEL-28 cells were incubated with 0.5 nM TYR 
hAuNPs in complete media for 4 hrs followed by a 12 hr hybridization period during 
which fresh media was added to the cells.  After incubation, treated melanoma cells were 
lifted from the plate and analyzed by flow cytometry which confirmed both a > 99%  
	  
Figure 31.  DNase I Susceptibility Assay.  TYR hAuNPs (2.2 nM, black) and TYR MBs 
(200 nM, red) treated with DNase (1U/L).  Rate of enzymatic degradation was determined by 
the slope of the initial linear region (shown above).  TYR hAuNPs rate of degradation: 0.097 
nmols/min.  TYR MB rate of degradation: 1.22 nmols/min.   
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transfection efficiency of nanoparticles and > 95% cell viability as compared to untreated 
cells. When compared to similar constructs such as nano-flares25, these hAuNP probes 
similarly diffuse into the mRNA-rich cytoplasm of the cell and maintain high cell 
viability.25  Since TYR hAuNPs readily enter cells without the need for transfection 
	  
	  
Figure 32.  Hairpin DNA-coated gold nanoparticle (hAuNP) labeling of SK-MEL-28 
melanoma cells.  Schematic representation of  the intercellular activity of non-specific 
mismatch (MM) hAuNPs (A) and tyrosinase-specific (TYR) hAuNPs (B).  Confocal imaging 
of SK-MEL-28 cells treated with MM hAuNPs (C) and TYR hAuNPs (D).  Flow cytometric 
analysis of SK-MEL-28 cells treated with MM hAuNPs (E) and TYR hAuNPs (F) with 
corresponding mean fluorescence values of 4k and 14K, respectively.  Scale bars: 20 µm 
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reagents, the ability of TYR hAuNPs to discriminate a specific intracellular mRNA target 
was investigated.  SK-MEL-28 cells were treated with TYR hAuNP and nonspecific 
mismatch (MM) hAuNPs and imaged by confocal microscopy.  TYR hAuNPs treated 
cells displayed a strong fluorescent signal while those treated with MM hAuNP treated 
cells showed none (figure 32C-D).  Flow cytometry was performed to quantitatively 
confirm the strong fluorescent signal observed in TYR hAuNP treated cells.   TYR 
hAuNP and MM hAuNP treated SK-MEL-28 cells exhibited a substantial difference in 
cellular fluorescence by which TYR hAuNP treated cells displayed a 3.5 fold increase in 
fluorescence as compared to MM hAuNP treated cells (figure 32E-F).  
 To test the ability of TYR hAuNPs to discern positive and negative expression of 
tyrosinase, SK-MEL-28 cells only, HEp2 cells only and a 50/50 mixed coculture of each 
were treated with 0.5 nM TYR hAuNPs and analyzed by scanning confocal microscopy. 
	  
Figure 33. RT-PCR Analysis of Tyr expression in SK-MEL-28 and HEp2 cells.  RNA 
isloated from SK-MEL-28 and HEp2 cells was subjected to RT-PCR and visualized by 
agarose gel electrophoresis.  The 289 bp tyrosinase PCR fragments were present in SK-MEL-
28 cells and absent from HEp2 cells.  The 232 bp β-actin PCR fragments were abundant for 
both cells lines. 
	  
	  
89	  
	  
HEp2 cells provide a viable non-melanocytic cellular control as they have a comparable 
hAuNP transfection rate (>99%), do not express tyrosinase and can be simultaneously 
cultured with SK-MEL-28 cells without compromising cell viability.    RT-PCR of 
cellular mRNA isolated from both SK-MEL-28 and HEp2 cells confirmed the presence 
and absence of tyrosinase mRNA, respectively (figure 33). 
	  
 
Figure 34. Coculture composite confocal imaging of hAuNP. Confocal fluorescence 
imaging of SK-MEL-28 cells only (A), HEp2 cells only (B), and a coculture of SK-MEL-28 
and  HEp2 cells(C) treated with 0.5nM TYR hAuNPs (red) and a live-cell nuclear stain, 
Syto13 (green).  DIC composite (left), Syto13 (center) and TYR hAuNP (right).  All images 
were captured with identical optical settings. Scale bar: 20 µm  
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 Thirty minutes prior to confocal imaging, cell cultures were treated with 100 nM 
Syto-13 to provide a comprehensive cellular marker that is ubiquitous to each cell type 
(Fig 2).   The tyrosinase expressing SK-MEL-28 cells displayed a strong TYR hAuNP 
signal localized to the cytosolic portion of the cell while TYR hAuNP fluorescence in 
HEp2 cells was not apparent at analogous detector gains.  Additionally, a TYR hAuNP 
treated coculture of SK-MEL-28 and HEp2 cells (50/50) unequivocally shows the 
potential of these novel mRNA probes to discriminate individual cells based on inherent 
gene expression.   
	  
Figure 35.  Z-stack confocal image of cocultured SK-MEL-28 and HEp2 cells.  Cells 
were treated with TYR hAuNPs (red) and the nuclear stain Syto13 (green).  The 3 
dimensional cutout at the top of the image shows TYR hAuNPs localized to the cytosolic 
portion of the cell and do not penetrate nucleus.  Scale bar: 20 µm 
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 Examination of the 3D confocal image obtained for the coculture image revealed 
the absence of colocalization with respect to the nucleus of the cell (figure 35).  The top 
z-plane explicitly shows the presence of the TYR hAuNPs evenly distributed in the 
cytoplasm while not colocalizing with the Syto13 stained nucleus.  Collectively, these 
results prove that TYR hAuNP probes are not only capable of detecting specific mRNA 
within the cell but that this information can be used to discriminate a cancerous cell from 
non-cancerous cell within a complex background.  Flow cytometry of the labelled 50/50 
mix of SK-MEL-28 and HEp2 cells confirmed two distinct populations (SK-MEL-28, 
51.3%; HEp2, 46.1%) with SK-MEL-28 cells exhibiting a 3-fold increase in cellular 
mean fluorescence as compared to the HEp2 cells (figure 36). 
  
 While the use of immortalized cell lines for the development of biodiagnostic 
tools is a common procedure, results do not always translate when applied to primary cell 
	  
 
Figure 36. Co-culture Flow Cytometric Analysis.  An equal number of SK-MEL-28 and 
HEp2 cells were treated with TYR hAuNP (0.5 nM) simulatiously in the same culture well.  
Flow cytometric analysis confirms the expected 50/50 cell type ratio with SK-MEL-28 cells 
exhibiting a 20-fold increase in Cy5 mean fluorescence (mean: 21K) as compared to the 
HEp2 cell population (mean: 1.2K). 
	  
	  
92	  
	  
culture conditions.  For this reason, we obtained primary melanoma cells excised from a 
66 year-old stage IIIC melanoma patient and treated them with both TYR hAuNPs and 
MM hAuNPs as previously described.  Confocal imaging confirmed the utility of this 
novel mRNA probe as shown by the intense fluorescence exhibited in the TYR hAuNP 
treated melanoma cells as compared to the MM hAuNP treated culture (figure 37).  
These results collectively demonstrate the ability of TYR hAuNPs to positively identify 
tyrosinase mRNA in primary melanoma cells.  
  
 Hairpin DNA functionalized gold nanoparticles represent an effective intercellular 
mRNA imaging tool.  These novel intercellular probes maintain advantages over 
traditional molecular mRNA imaging techniques in that no transfection reagents are 
needed, they are resistant to nuclease degradation and they provide an assessment of gene 
expression at the single cell level.  Their efficacy in primary cell cultures provides an 
	  
Figure 37. Confocal fluorescence imaging of primary melanoma cells from a 66 year-old 
stage IIIC melanoma patient.  Melanoma cells were treated with either TYR hAuNPs (left) or 
MM hAuNPs (right).  Images were captured with identical optical parameters.  hAunPs (red) 
and Syto13 (green).  Scale bars: 20 µm 
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avenue for exploring more complex diagnostic capabilities including individual gene 
expression profiling for a variety of cancer types including melanoma.   
 To further explore the utility of hAuNPs as discriminative intracellular mRNA 
probes, we designed two additional melanoma marker probes (S100β and MIA) and a 
housekeeping probe (βactin) to serve as  a universal marker for cell type variability.32-34  
The S100β protein is a calcium binding protein that is constitutively expresses in brain 
astrocytes and malignant melanoma.34  A common approach for detection of metastatic 
disease is the analysis of S100β in the serum of melanoma patients.35  An elevation of 
this protein has been observed in patients with malignant melanoma, and a positive 
correlation with disease progression has been demonstrated.5  Another emerging 
serological marker is the melanoma inhibitory activity (MIA) protein.36  MIA has been 
identified as a small protein secreted from malignant melanoma cells that inhibits 
integrin-matrix binding which promotes cell migration.37  Unlike the tyrosinase gene, 
MIA gene expression has only been observed in metastatic melanoma and absent in 
normal skin-derived melanocytes.  Incorporation of these two targets with the proven 
TYR probe allows for development of a intracellular gene expression profile that can 
easily be performed with standard flow cytometric analysis. 
 As with the TYR probe design, extensive BLAST search comparison was 
performed to ensure complete overlap of the recognition sequence with each respective 
mRNA molecule.  The S100β and MIA probe design incorporated a 3' Quasar 670 
fluorophore and the βactin probe was designed with a terminal Quasar 570 fluorophore 
(Cy3 equivalent).  The sequences for each target are shown in table 3.  Dithiolthreitol 
reduction of the S100β, MIA and βactin probes resulted in oligonucleotide-to-particle 
94	  
	  
ratios of ~110, ~100 and ~120 DNA strands per hAuNP, respectively.  Absorption 
spectroscopy confirmed the characteristic 522 nm plasmon peak remained unchanged 
after covalent attachment of DNA for each probe. 
 
Table 3.  Melanoma hAuNP Oligonucleotide Sequence Information 
Melanoma hAuNP Profile Probe Sequences 
 Oligonucleotide Probe Sequence (5'-3')* 3' Dye 
Tyr Probe T10-GCACG ATTGTGCATGCTGCTTTGAG CGTGC Quasar 670 
S100β Probe T10-GCACG CAGTAGTAACCATGGCAACA CGTGC Quasar 670 
MIA Probe T10-GCACG AGGTTTCAGGGTCTGGTCCT CGTGC Quasar 670 
MM Probe T10-GCACG ACTCAAGGCACATCGCAATA CGTGC Quasar 670 
βactin Probe T10-GCACG GGAGTTGAAGGTAGTTTCGT CGTGC Quasar 570 
*All sequences incorporate a 5' C6 thiol. 
**Underlined represent hairpin formation sequences. 
 
	  
 
Figure 38.  hAuNP Specificity of Melanoma Profile Probes.  hAuNPs signal-to-noise ratios 
were determined by in vitro incubation with complementary and non-complementary 
oligonucleotides.  S/N ratios were determine by comparison of specific vs nonspecific 
fluorescent signal.   
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 To confirm target specificity of each probe in vitro, hAuNPs (1 nM) were 
incubated with the appropriate 20 base complement versus a 20 base non-complementary 
oligonucleotide for 2 hr at 37oC.  As previously shown with TYR hAuNPs, each probe 
displays good specificity with > 3 fold increase in signal in the presence of the respective 
proper complement when compared to mismatch DNA (figure 38).  In vivo confocal 
imaging of SK-MEL-28 cells treated with each melanoma marker probe confirmed 
intracellular utility of each probe, each having pronounced fluorescent signals as 
compared to control experiments  (figure 39). 
	  
	  
Figure 39.  Scanning Confocal Imaging of Melanoma Profile hAuNPs.  SK-MEL-28 cells 
were treated with 25 nM syto-13 nuclear stain (green), 5 nM MitoTracker (blue) and hAuNPs 
(red).  Images were obtained with identical optical setting. 
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 In melanoma progression, a variety of gene mutations occur that can initiate 
metastasis that influence melanoma progression.38  The specifics associated with which 
genes are expressed rely on a signature phenotype for cancers such as melanoma. For 
example, the RAF kinase pathway mediates cellular responses to growth signals.39  The 
BRAF somatic missense mutation is observed in over 60% of malignant melanomas39 
while another subset code for oncogenic mutations in KIT which code for nearly 20% of 
all melanoma mutations.38  Each mutant oncogene responds differently to current 
treatment protocols.40  This highlights the need for accurate and timely determination of 
malignant melanoma phenotype.  By incorporating multiple melanoma expression targets 
into the hAuNP system, the goal is to develop a quick and non-invasive method for 
identifying the phenotypic classification of clinical melanoma diagnosis. 
 To explore the ability of hAuNPs to effectively discriminate phenotypic 
characteristics of malignant melanoma, a multicellular hAuNP profile experiment was 
performed using three melanoma-specific expression markers and a housekeeping β-actin 
probe for evaluation of phenotypic variations between  human melanoma cell lines.  To 
do this, the cell lines SK-MEL-28, Wm115, MeWo, and HS-294T human melanoma cell 
lines as well as the non-melanocytic HEp2 cell line were treated  with  0.25 nM 
melanoma marker hAuNPs and 0.25 nM βactin hAuNPs followed by flow cytometric 
analysis.  To form comparative expression values, the mean fluorescence of each probe 
was divided by the mean fluorescence of the βactin probe, which served as an internal 
control for cellular variability.  Each hAuNP expression value was then normalized to the 
mismatch probe to give relative hAuNP expression values for each gene target as shown 
in the following equation: 
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α =  hAuNP relative expression value 
 
Table 4.  hAuNP Expression Values for Multiple Melanoma Cell Lines 
hAuNP Melanoma Expression Values 
 TYR MIA S100β 
SK-MEL-28 1.94 ± 0.29 1.19 ± 0.04 1.01±0.19 
Wm115 1.06 ± 0.10 1.04 ± 0.08 0.96 ± 0.05 
MeWo 1.08 ± 0.10 1.16 ± 0.04 1.02 ± 0.17 
HS-294T 1.13 ± 0.26 1.19 ± 0.16 1.04 ± 0.17 
HEp2 1.02 ± 0.05 0.99 ± 0.03 1.13 ± 0.13 
	  
Figure 40.   hAuNP Expression Values for Multiple Melanoma Cell Lines.	   	   (blue) 
Tyrosinase expression values, (red) MIA hAuNP expression values and (black) S100 hAuNP 
expression values.	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 The results of the hAuNP expression profile explicitly show that SK-MEL-28 
cells have high expression of tyrosinase as compared to the other melanoma cell lines 
(figure 40; table 4). Additionally, MIA expression levels were consistently higher each 
melanoma cell line.  Interestingly, S100β values were not very conclusive and in fact, 
HEp2 cells displayed a slightly higher S100β signal.  Extensive literature research does 
not indicate S100β expression in HEp2 cell lines but more insight is needed to evaluate 
this observation.   
 To assess the accuracy of the hAuNP melanoma expression profile, RT-PCR was 
performed for each cell line to determine the comparative expression values for each 
melanoma oncogene.  The gene expression values were based on Ct values which were 
based on the comparative Ct method where the relative transcript level of each target 
gene was calculated according to the equation 2-ΔCt, where ΔCt is defined as Ct target 
	  
	  
Figure 41.  RT-PCR Relative Transcription Ratios for Experimental Cell Lines.   
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gene - Ct βactin gene (figure 41; table 5). 
Table 5.  RT-PCR Relative Transcription Ratios for Multiple Melanoma Cell Lines 
RT-PCR Melanoma Ct Values 
 TYR MIA S100β 
SK-MEL-28 4.68 ± 0.09E-3 1.59 ± 0.04E-3 1.96 ± 0.06E-4 
Wm115 1.26 ± 0.06E-6 6.10 ± 0.23E-4 3.86 ± 0.06E-4 
MeWo 1.85 ± 0.01E-5 2.17 ± 0.05E-4 3.94 ± 0.04E-4 
HS-294T 7.74 ± 0.20E-6 5.93 ± 0.06E-4 6.95 ± 0.02E-4 
HEp2 N/A N/A 3.89 ± 0.03E-5 
 
 At first glance, the majority of expression variability as a whole was too 
insignificant to form an accurate assessment of melanoma phenotype but a significant 
difference was observed for SK-MEL-28 cells in both gene expression assessments.  The 
most apparent result showed a strong correlation of tyrosinase expression in both hAuNP 
and RT-PCR experiments.  Another observation was the elevated MIA hAuNP values for 
melanoma cell lines which didn't discriminate between cell lines but did correlate to the 
absence of HEp2 comparative RT-PCR values.  Furthermore, the similar lack of 
magnitude of expression values for each method could actually be attributed to cell type.  
To the best of our knowledge, this is the first study that has analyzed comparative RT-
PCR of tyrosinase mRNA across these particular melanoma cell lines.  The analogous 
measurement by the hAuNP expression value profile demonstrates the potential of 
hAuNP as a future diagnostic tool.  The possibility of using these intracellular mRNA 
probes for measuring a cancer cell's gene expression profile in a matter of hours could 
greatly assist in a more accurate diagnosis and treatment. 
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Conclusions 
 As we learn more about the systematic process of cellular function, the need and 
demand for new intracellular tools capable of relaying accurate information regarding 
cellular status is of utmost importance.  Unlike foreign microbes, cancerous cells do not 
exhibit intrinsic characteristics that are recognized by the body's immune system and 
therefore remain to be the focus of continued research. New paradigms are beginning to 
emerge due to focused attention on cellular dysfunction, namely gene expression.  The 
most common technique for measuring gene expression is RT-PCR but while sensitive 
and well excepted, the extensive sample preparation, high risk of false results due to 
contamination and need to extract mRNA from a large population of cells does not make 
this technique viable for future clinical use.  The ability to evaluate and measure statistics 
on a single cell level have yet to be mastered completely but emerging microfluidic 
technology as well as micro-analytical technologies holds promise for such future 
applications.   
 Herein, a new intracellular mRNA recognition nanoparticle probe is presented 
that is capable of discriminating melanoma cells, both primary and immortilized, from 
mixed cell cultures.  The hAuNP construct is a unique intracellular probe due to its 
inherent ability to accumulate in the cytoplasm of the cell, lack of cytotoxicity and 
decreased nuclease susceptibility.  The fluorescence quenching nature of the gold 
nanoparticle provides the needed 'on/off' switch that relays information upon target 
mRNA binding events.27   The difference associated with live cell measurements of gene 
expression versus end-point measurements such as RT-PCR have yet to be sufficiently 
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evaluated which highlights the need for novel methods for live-cell gene analysis.  The 
vast array of knowledge associated with cancer-associated gene expression is constantly 
growing with much to learn in the future.  Having clinical tools to personalize cancer 
diagnostics is of utmost importance for initial diagnosis, post-treatment assessments and 
phenotypic evaluation which will maximize treatment efficacy.  Nanoscale diagnostic 
probes such as hairpin DNA coated gold nanoparticles provide a functional means to 
developing tools that will revolutionize the way society approaches cancer diagnosis and 
treatment. 
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Future Directions 
 In recent years, there have been a variety of gold nanoparticle diagnostics 
developed that address many issues associated with  vaccine development, 
protein/antigen detection and intracellular delivery, detection and modulation.  Each 
subset has great potential to incrementally revolutionize modern diagnostics as we see it 
today.  The intracellular mRNA detection probe presented in this chapter is merely a well 
developed prototype capable of addressing many of the current hurdles associated with 
live cell imaging of intracellular mRNA.  In addition to their overall cellular 
compatibility, hAuNPs, provide a unique real-time quantitative assessment of 
intracellular mRNA using well established techniques such as flow cytometry and 
confocal microscopy.   
 The hAuNP modular design was inspired by traditional DNA beacon technologies 
and is far from optimized for maximum efficacy in regards to the size and ratio of the 
stem-loop DNA.  Additionally, a better understanding of the exact orientation of surface 
hairpin oligonucleotides as well as the influence of hairpin secondary structure is needed. 
Several experiments were performed that incorporated various molar ratios of thiolated 
spacer ligands including 6-mercaptohexanoic acid (MHA) and C6- thiol T10 
oligonucleotides but were not effective due to aggregation issues (MHA) and no 
appreciable increase in signal-to-noise.  The gold particle size (15 nm) used for this study 
proved to be an effective scaffold with ~ 100 strands per particle but there is plenty to be 
learned from different sizes and shapes which modulate the gold plasmon peak to expand 
the range of quenchable fluorophores. 
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 The current experimental protocol for cellular hAuNP loading was optimized for 
0-3 nM solutions and 8-12 hr hybridization periods but due to time constraints, higher 
hAuNP loading concentrations and shorter hybridization periods should be explored to 
expand the robustness and throughput of the probe.  The current protocol requiring a 4 hr 
hAuNP loading and 12 hr hybridization period is a very taxing experimental design for 
future researchers due to the elongated processing time.  Refinement in this area will 
allow for increase experimental throughput as well as a much more sustainable 
experiment design for the researcher. 
 There are several oligonucleotide design areas that would greatly benefit from 
modest financial investments.  First, the incorporation of locked nucleic acids or o-methyl 
nucleic acids would essentially eliminate the intracellular endogenous nuclease activity 
resulting in  reduced background noise in all aspects.  One potential side-effect of these 
nuclease resistant oligonucleotides is a disruption of the salt-stabilization phenomenon 
which can only be determined experimentally.  Secondly, the recognition sequences used 
for each probe in this chapter were designed from a published antisense primer.  While 
the current method proves to be successful by comparison to the designed mismatch 
sequence, the evaluation of multiple recognition sites for a single mRNA target would be 
useful for accurately identifying an optimum recognition sequence.  Additionally, 
multiple recognition sites for a single mRNA molecule could lend to multiplexed 
hAuNPs that could overcome low expression by increaseing the signal x-fold, where x is 
equivalent to the number of viable recognition sequences for a single target. 
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